Included under terms of UK Non-commercial Government License.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Nyssen OP, Taylor SJC, Wong G, et al. Does therapeutic writing help people with long-term conditions? Systematic review, realist synthesis and economic considerations. Southampton (UK): NIHR Journals Library; 2016 Apr. (Health Technology Assessment, No. 20.27.)
Does therapeutic writing help people with long-term conditions? Systematic review, realist synthesis and economic considerations.
Show detailsStudy design
TABLE 98
First author, year | Country | Study design | n of intervention groups | n of control groups |
---|---|---|---|---|
Abel 200450 | USA | RCT | 1 | 1 |
Arden-Close 201380 | UK | RCT | 1 | 1 |
Averill 2013100 | USA | RCT | 1 | 1 |
Bartasiuniene 2011102 | Lithuania | RCT | 1 | 2 |
Bernard 200693 | UK | RCT | 1 | 1 |
Broderick 2004113 | USA | RCT | 2 | 1 |
Broderick 2005118 | USA | RCT | 1 | 1 |
Canna 200694 | USA | RCT | 2 | 2 |
Cepeda 200885 | Colombia | RCT | 1 | 2 |
Craft 201374 | USA | RCT | 2 | 2 |
Dennick 201488 | UK | RCT | 1 | 1 |
D’Souza 2008101 | USA | RCT | 1 | 1 |
Gellaitry 201075 | UK | RCT | 1 | 1 |
Gidron 199698 | Israel | RCT | 1 | 1 |
Gillis 2006119 | USA | RCT | 1 | 1 |
Golkaramnay 200768 | Germany | Controlled cohort | 1 | 1 |
Graf 200895 | USA | RCT | 1 | 1 |
Graham 200851 | USA | RCT | 1 | 1 |
Grasing 201090 | USA | RCT | 1 | 1 |
Halpert 201052 | USA | Controlled cohort | 1 | 1 |
Hamilton-West 2007114 | UK | RCT | 1 | 1 |
Harris 2005106 | USA | RCT | 2 | 1 |
Henry 201053 | USA | Case–control | 1 | 1 |
Hevey 2012103 | Ireland | RCT | 1 | 1 |
Hong 201167 | Korea | RCT | 1 | 1 |
Hughes 200754 | USA | RCT | 1 | 1 |
Ironson 201371 | USA | RCT | 1 | 1 |
Jensen-Johansen 201376 | Denmark | RCT | 1 | 1 |
Kraaij 201055 | Netherlands | RCT | 1 | 1 |
Krpan 201396 | USA | RCT | 1 | 1 |
Lange 200369 | Netherlands | RCT | 1 | 1 |
Lumley 2011115 | USA | RCT | 2 | 1 |
Lumley 2014116 | USA | RCT | 2 | 2 |
Mann 200172 | USA | RCT | 1 | 1 |
McElligott 200687 | USA | Non-RCT | 1 | 1 |
Meshberg-Cohen 201091 | USA | RCT | 1 | 1 |
Milbury 201481 | USA | RCT | 1 | 1 |
Mosher 201277 | USA | RCT | 1 | 1 |
Paradisi 2010110 | Italy | RCT | 2 | 1 |
Park 201278 | Korea | Controlled cohort | 1 | 1 |
Pauley 201182 | USA | RCT | 2 | 1 |
Petrie 200456 | New Zealand | RCT | 1 | 1 |
Richards 200097 | USA | RCT | 1 | 2 |
Rickett 201166 | Australia | RCT | 1 | 1 |
Rini 201486 | USA | RCT | 3 | 1 |
Robinson 200899 | UK | RCT | 1 | 1 |
Rosenberg 200283 | USA | RCT | 1 | 1 |
Sharifabad 2010105 | USA | RCT | 1 | 1 |
Sloan 201270 | USA | RCT | 1 | 1 |
Smyth 1999107 | USA | RCT | 1 | 1 |
Smyth 2008121 | USA | RCT | 1 | 1 |
Stark 201057 | USA | RCT | 3 | 1 |
Tabolli 2012111 | Italy | RCT | 1 | 1 |
Taylor 200389 | USA | RCT | 1 | 1 |
Theadom 201058 | UK | RCT | 1 | 1 |
Van Dam 201392 | Netherlands | RCT | 1 | 1 |
Vedhara 2007112 | New Zealand | RCT | 1 | 1 |
Wagner 201073 | USA | RCT | 1 | 1 |
Walker 199979 | USA | RCT | 2 | 1 |
Wallander 2011109 | USA | RCT | 1 | 1 |
Warner 2006108 | USA | RCT | 1 | 1 |
Wetherell 2005117 | UK | RCT | 1 | 1 |
Willmott 2011104 | UK | RCT | 1 | 1 |
Zakowski 200484 | USA | RCT | 1 | 1 |
Participants’ conditions
TABLE 99
First author, year | LTC | ICD-10 code | LTC: inclusion criteria/diagnostic tool(s) |
---|---|---|---|
Abel 200450 | HIV | B24 | Taking ART for their diagnosis, able to report their last VL of < 80 000–100,000 copies/ml, free of major psychiatric problems (self-report) |
Arden-Close 201380 | Ovarian cancer | C56 | Disease stage from I to IV, with CA125 level checked by oncologist and categorised above or below 35 U/ml for the prognosis of the cancer and within 5 years of treatment |
Averill 2013100 | ALS | G12 | Definite or probable ALS using El Escorial criteria at least 6 months prior to study entry (World Federation of Neurology Research Group on Neuromuscular Diseases, 1994); FVC in the 50th percentile or higher |
Bartasiuniene 2011102 | CVD | I51 | |
Bernard 200693 | PTSD | F43 | First episode of psychosis conforming to broad ICD-10 criteria (F20, F22, F23, F25) |
Broderick 2004113 | RA | M06 | Formal diagnosis of RA |
Broderick 2005118 | FM | M79 | Formal diagnosis of FM by a physician |
Canna 200694 | Axis I anxiety or mood disorder | F41 | Individuals with axis I anxiety or mood disorder primary diagnosis |
Cepeda 200885 | Cancer | C80 | Any type of cancer and reporting average pain intensity levels of at least 5/10 on a 0–10 scale; scored > 50% in the Karnofsky scale |
Craft 201374 | Breast cancer | C50 | Invasive or non-invasive early stage breast cancer, definitive treatment (surgery, chemotherapy and/or radiation therapy) completed, time from diagnosis < 2 years |
Dennick 201488 | Type 2 diabetes mellitus | E11 | |
D’Souza 2008101 | Tension/migraine headaches | G43/G44 | International Headache Society criteria for either tension or migraine headaches |
Gellaitry 201075 | Breast cancer | C50 | Patients with early-stage breast cancer, attending the last radiotherapy appointment at the outpatient clinic and without a defined psychiatric disorder |
Gidron 199698 | PTSD | F43 | PTSD assessed with the Mississippi Scale for PTSD |
Gillis 2006119 | FM | M79 | Rehabilitation hospital patients with CVD |
Golkaramnay 200768 | Mental disorders | F41–F60 | Inpatient from hospital with mental health conditions according to the ICD-10 criteria |
Graf 200893 | Psychiatric disorder | F99 | Participants from an university-based outpatients’ psychiatric clinic and student counselling centre |
Graham 200851 | Chronic pain | Unclassifiable | Patients had experience for at least 6 months and were recruited during routine visits to a university hospital-affiliated outpatient pain centre |
Grasing 201090 | Cocaine dependence | F14 | Meeting DSM-IV criteria for cocaine dependence at the time of admission |
Halpert 201052 | IBS | K58 | Fulfilled the Rome III Criteria for IBS |
Hamilton-West 2007114 | AS | M45 | Inflammation of the joints in the pelvis; low back pain and stiffness for > 3 months, which improves with exercise but is not relieved by rest; limited movement of the lower back and restricted chest expansion |
Harris 2005106 | Asthma | J45 | Asthma was confirmed by a history of asthma diagnosed by a physician and either evidence of reduced expiratory volume and reversibility obtained through medical records or evidence of reduced expiratory volume evaluated by study staff |
Henry 201053 | Breast cancer | C50 | Female breast cancer survivors attending radiation oncology clinics |
Hevey 2012103 | MI | I21 | Patients with confirmed MI, who received treatment at a large teaching hospital |
Hong 201167 | Dementia (Alzheimer’s disease/vascular dementia/Parkinson’s disease) | F03 (F00/F01/F02) | Elderly people housed in a nursing home and already medically diagnosed with dementia, and scoring ≤ 19 on the MMSE-K |
Hughes 200754 | Breast cancer | C50 | Stage I, II or III breast cancer women receiving curative radiation therapy for breast cancer |
Ironson 201371 | HIV (plus PTSD) | B24 (plus F43) | HIV-positive, falling into a CD4 range of 100–600. Included were also those with one Category C symptom (AIDS defining) but without C symptoms 1 year prior to study entry. The stress of HIV was considered sufficient to enter the study and no other trauma was required |
Jensen-Johansen 201376 | Breast cancer | C50 | Female Danish residents, able to read and write Danish, aged 18–70 years, and treated surgically within 3 weeks of their diagnosis (mastectomy or lumpectomy) for invasive breast cancer, stages I and II |
Kraaij 201055 | HIV | B24 | HIV-diagnosed patients. No restricted criteria regarding the VL or the CD4+ count |
Krpan 201396 | Depression | F41 | According to SCID |
Lange 200369 | PTSD | F43 | Participants had to score below the cut-off scores of the Depression subscale of the SCL-90 in the Dutch norm, the SDQ-5, and the Dutch Screening Device for Psychotic Disorder of the Dutch norm group |
Lumley 2011115 | RA | M06 | Patients with RA who met American College of Rheumatology criteria for non-juvenile RA. Patients had to report experience pain or disability due to their RA in the preceding week |
Lumley 2014116 | RA | M06 | RA patients meeting American College of Rheumatology criteria for non-juvenile RA. Patients had to report experience pain or disability due to their RA in the preceding week |
Mann 200172 | HIV | B24 | Women being treated for HIV or diagnosed with AIDS |
McElligott 200687 | Sickle cell disease | D57 | Medically diagnosed with sickle cell disease |
Meshberg-Cohen 201091 | SUD | F19 | The Structured Clinical Interview for DSM-IV-TR – Alcohol and Substance Use Disorders Module (SCID) was used as the diagnostic interview assessing SUD diagnosis, including alcohol and other drugs |
Milbury 201481 | RCC | C64 | Newly diagnosed with stage I–IV RCC and with a Zubrod performance status of < 2 |
Mosher 201277 | Breast cancer | C50 | Distressed women with stage IV breast cancer |
Paradisi 2010110 | Psoriasis | L40 | Plaque-type psoriasis involving > 10% of body area |
Park 201278 | Breast cancer | C50 | Stage II and III, breast cancer survivors, women. No restriction to staging, surgery or drugs intake |
Pauley 201182 | Testicular cancer | C62 | Testicular cancer survivors, men. No restriction to staging, surgery or drugs intake |
Petrie 200456 | HIV | B24 | Documented HIV infection and not had their classified oral drug regimen changed in the previous 12 months |
Richards 200097 | Mental disorder | F41–F60 | Diagnosed with at least one mental disorder, as classified with the DSM-III-R |
Rickett 201166 | Cancer | C80 | All diagnosed with cancer except for one participant with a history of severe CVD, and one with an autoimmune disorder |
Rini 201486 | Following stem cell transplant | C80 | |
Robinson 200899 | BN | F50 | Diagnosis was made using information from the QEDD using DSM-IV (American Psychiatric Association, 1994) for definitions of disorders. Included were those with a diagnosis of BN (purging or non-purging) |
Rosenberg 200283 | Prostate cancer | C61 | Histological diagnosis of adenocarcinoma of the prostate being followed with serial PSAs. Previously local treatment (prostatectomy or radiation) within the last 4 years |
Sharifabad 2010105 | COPD plus IPF | J44 plus J84 | Medically diagnosed with COPD or IPF |
Sloan 201270 | PTSD | F43 | Participants met DSM-IV PTSD Criterion A for a traumatic stressor (American Psychiatric Association, 1994) |
Smyth 1999107 | Asthma/RA | J45/M06 | RA diagnosis was confirmed by board-certified rheumatologists and all patients met American College of Rheumatology criteria Asthma was diagnosed by a history of asthma, confirmed by a physician; patients were also required to provide a documented reduction in expiratory function (either in physician records or when evaluated by study staff) |
Smyth 2008121 | PTSD | F43 | Based on PTSD diagnosis verification defined by the DSM-IV |
Stark 201057 | FM plus facial pain | M79 | Diagnosis made by the referring physician |
Tabolli 2012111 | Psoriasis | L40 | Diagnosis by an experienced staff dermatologist, according to established internationally accepted criteria, with ≥ 10% of body surface affected |
Taylor 200389 | Cystic fibrosis | E84 | Medically diagnosed with cystic fibrosis |
Theadom 201058 | Asthma | J45 | Diagnosed with asthma and requiring regular inhaled medication (British Thoracic Society step 2 or higher; British Thoracic Society and Scottish Intercollegiate Guidelines Network, 2005) |
Van Dam 201392 | SUD | F14 | Diagnosed with SUD |
Vedhara 2007112 | Psoriasis | L40 | A clinically verified diagnosis of psoriasis for at least 6 months |
Wagner 201073 | HIV | B24 | Diagnosed with HIV only |
Walker 199979 | Breast cancer | C50 | Women completing radiation therapy for breast cancer stage I or II with a Karnofsky performance status of ≥ 70% |
Wallander 2011109 | GI RAP | R10 | Patients with GI RAP, who met Apley’s (1975) criteria for functional RAP as determined by a paediatric GI specialist |
Warner 2006108 | Asthma | J45 | Participants classified with mild, persistent asthma (i.e. asthma symptom activity at least 2 days per week and nocturnal symptoms at least twice monthly) |
Wetherell 2005117 | RA | M06 | Diagnosed with RA |
Willmott 2011104 | MI | I21 | Participants were the first patients with MI who were receiving treatment at two acute hospital clinics |
Zakowski 200484 | Prostate plus gynaecological cancer | C61 (prostate) plus C55 (uterus), C56 (ovary), C53 (cervix) | Participants with a first-time diagnosis of prostate or gynaecological cancer within the last 5 years |
AIDS, acquired immunodeficiency virus; MMSE-K, Mini Mental State Examination Korean Version; PSA, prostate-specific antigen; SCL-90, Symptom Checklist-90; SDQ-5, somatoform dissociation questionnaire-5.
Included studies categorised by International Classification of Diseases, Tenth Edition code by the reviewers
TABLE 100
First author, year | LTC | ICD-10 code |
---|---|---|
Abel 200450 | HIV | B24 |
Kraaij 201055 | HIV | B24 |
Mann 200172 | HIV | B24 |
Petrie 200456 | HIV | B24 |
Wagner 201073 | HIV | B24 |
Ironson 201371 | HIV (plus PTSD) | B24 |
Craft 201374 | Breast cancer | C50 |
Gellaitry 201075 | Breast cancer | C50 |
Henry 201053 | Breast cancer | C50 |
Hughes 200754 | Breast cancer | C50 |
Jensen-Johansen 201376 | Breast cancer | C50 |
Mosher 201277 | Breast cancer | C50 |
Park 201278 | Breast cancer | C50 |
Walker 199979 | Breast cancer | C50 |
Arden-Close 201380 | Gynaecological and genitourinary cancer | C57 (ovarian) |
Rosenberg 200283 | Gynaecological and genitourinary cancer | C61(prostate) |
Zakowski 200484 | Gynaecological and genitourinary cancer | C61 (prostate) plus C55 (uterus), C56 (ovary), C53 (cervix) |
Pauley 201182 | Gynaecological and genitourinary cancer | C62 (testicular) |
Milbury 201481 | Gynaecological and genitourinary cancer | C64 |
Cepeda 200885 | Cancer from various sources | C80 |
Rickett 201166 | Cancer from various sources | C80 |
Rini 201486 | Cancer from various sources | C80 |
McElligott 200687 | Sickle cell disease | D57 |
Taylor 200389 | Cystic fibrosis | E84 |
Hong 201167 | Dementia (Alzheimer’s disease/vascular dementia/Parkinson’s disease) | F03 (F00/F01/F02) |
Grasing 201090 | Cocaine dependence | F14 |
Meshberg-Cohen 201091 | SUD | F19 |
Van Dam 201392 | SUD | F19 |
Bernard 200693 | First episode psychosis | F41–F60 |
Canna 200694 | Mental disorder (Axis I anxiety or mood disorder) | F41–F60 |
Golkaramnay 200768 | Mental disorder | F41–F60 |
Richards 200097 | Mental disorder | F41–F60 |
Graf 200895 | Mental disorder (psychiatric disorder) | F41–F60 (F99) |
Krpan 201396 | Depression | F41 |
Gidron 199698 | PTSD | F43 |
Lange 200369 | PTSD | F43 |
Sloan 201270 | PTSD | F43 |
Smyth 2008121 | PTSD | F43 |
Robinson 200899 | BN | F50 |
Averill 2013100 | ALS | G12 |
D’Souza 2008101 | Tension/migraine headaches | G43/G44 |
Hevey 2012103 | MI | I21 |
Willmott 2011104 | MI | I21 |
Bartasiuniene 2011102 | CVD | I51 |
Sharifabad 2010105 | COPD plus IPF | J44 plus J84 |
Harris 2005106 | Asthma | J45 |
Theadom 201058 | Asthma | J45 |
Warner 2006108 | Asthma | J45 |
aSmyth 1999107 | Asthma/RA | J45/M06 |
Halpert 201052 | IBS | K58 |
Wallander 2011109 | IBS (GI RAP) | K58 (R10) |
Paradisi 2010110 | Psoriasis | L40 |
Tabolli 2012111 | Psoriasis | L40 |
Vedhara 2007112 | Psoriasis | L40 |
Broderick 2004113 | RA | M06 |
Lumley 2011115 | RA | M06 |
Lumley 2014116 | RA | M06 |
Wetherell 2005117 | RA | M06 |
Hamilton-West 2007114 | AS | M45 |
Broderick 2005118 | FM | M79 |
Gillis 2006119 | FM | M79 |
Stark 201057 | FM | M79 |
Graham 200851 | Chronic pain | M79 |
- a
Smyth et al.107 has been reported twice under J45 and M06/M45 ICD-10 categories.
Note that this table includes the studies classified as assessing an unfacilitated TW intervention.
Interventions assessed
Interventions assessed
TABLE 101
First author, year | Experimental condition | Control condition | ||
---|---|---|---|---|
Intervention group 1 | Intervention group 2 | Control group 1 | Control group 2 | |
Abel 200450 | EW disclosure (unfacilitated type of TW) | Daily activities writing | ||
Arden-Close 201380 | Written emotional disclosure (unfacilitated type of TW) | Details of previous day writing | ||
Averill 2013100 | Written or oral expressive disclosure (unfacilitated type of TW) plus completion of study measures | Attentional control writing (completion of study measures) | ||
Bartasiuniene 2011102 | Expressive writing (unfacilitated type of TW) | Daily events writing | Non-writing group (wrote nothing) | |
Bernard 200693 | Written emotional disclosure (unfacilitated type of TW) | Non-EW (activities that day, the room they were in, and plans for the next week) | ||
Broderick 2004113 | Standard expressive writing (unfacilitated type of TW) | Enhanced meaning writing | Day-to-day activities in relation to the time invested | Educational attention control group |
Broderick 2005118 | Written emotional expression with cognitive reappraisal | Day-to-day activities in relation to the time invested | Non-writing (usual care) | |
Canna 200694 | Expressive writing plus CBT | CBT | Inexpressive writing plus CBT | Waiting list |
Cepeda 200885 | Narrative emotional disclosure | Questionnaire writing | Usual care | |
Craft 201374 | Breast-cancer trauma writing (unfacilitated type of TW) | Self-selected trauma writing (unfacilitated type of TW) | Breast cancer factual writing (unfacilitated type of TW) | Non-writing |
Dennick 201488 | Written emotional disclosure | Previous day’s activities | ||
D’Souza 2008101 | Written emotional disclosure (unfacilitated type of TW) | Time-management control writing | ||
Gellaitry 201075 | Expressive writing (unfacilitated type of TW) | Routine care | ||
Gidron 199698 | Written disclosure (unfacilitated type of TW) plus oral disclosure of most severe event | Casual daily agenda writing plus oral disclosure of daily activity | ||
Gillis 2006119 | Written emotional disclosure (unfacilitated type of TW) | Time-management writing | ||
Golkaramnay 200768 | Group therapy through internet chat | No intervention | ||
Graf 200895 | Written emotional disclosure (unfacilitated type of TW) | Plans for the rest of the day writing | ||
Graham 200851 | Written anger expression through letter-writing format (Rusing and Nolen-Hoeksema type of TW) | Goals writing through letter-writing format | ||
Grasing 201090 | Written emotional expression (Pennebaker type of TW) | Time-management writing | ||
Halpert 201052 | Expressive writing (unfacilitated type of TW) | Non-writing | ||
Hamilton-West 2007114 | EW exercise (unfacilitated type of TW not approved by ethics committee – adapted version used) | Time-management exercise | ||
Harris 2005106 | Stressful experiences writing | Positive writing | Neutral topic writing | |
Henry 201053 | Positive expressive writing (single episode unfacilitated type of TW) | Usual care | ||
Hevey 2012103 | Expressive writing (single episode unfacilitated type of TW) | Daily activities writing in the year prior to heart attack | ||
Hong 201167 | Songwriting | Waiting list | ||
Hughes 200754 | Expressive writing | Usual care | ||
Ironson 201371 | Augmented trauma writing (unfacilitated type of TW) plus processing probes | Daily event writing | ||
Jensen-Johansen 201376 | Expressive writing (unfacilitated type of TW) | Daily activities writing | ||
Kraaij 201055 | Structured writing intervention (through website) | Cognitive–behavioural self-help programme | Waiting list | |
Krpan 201396 | Expressive writing (deepest thoughts and feelings) | How they organised their day | ||
Lange 200369 | Interapy | Waiting list | ||
Lumley 2011115 | Written or oral emotional disclosure | Positive writing (or talking) | Neutral topic writing (or talking) | |
Lumley 2014116 | Expressive writing, coping skills training | Neutral writing, coping skills training | ||
Mann 200172 | Positive future writing | Non-writing | ||
McElligott 200687 | Expressive writing (unfacilitated type of TW) | Details of previous day writing | ||
Meshberg-Cohen 201091 | Expressive writing (unfacilitated type of TW) | Neutral topic writing | ||
Milbury 201481 | Expressive writing (unfacilitated type of TW) | Neutral topic writing | ||
Mosher 201272 | Expressive writing | Neutral topic writing | ||
Paradisi 2010110 | Written emotional disclosure (unfacilitated type of TW) | Positive future writing (unfacilitated type of positive TW) | Non-emotional disclosure | |
Park 201278 | Expressive writing programme (unfacilitated type of TW) | No intervention | ||
Pauley 201182 | Negative expressive writing (unfacilitated type of TW) | Positive expressive writing (unfacilitated type of TW) | Innocuous writing | |
Petrie 200456 | Written emotional expression (unfacilitated type of TW) | Time-management writing | ||
Richards 200097 | Trauma writing (unfacilitated type of TW) | Trivial writing | Usual routine | |
Rickett 201166 | Poetry writing programme/workshop | Waiting list | ||
Rini 201486 | Expressive writing | Peer helping, expressive helping | Neutral writing | |
Robinson 200899 | eBT | Unsupported SDW (unfacilitated type of TW) | Waiting list | |
Rosenberg 200283 | Expressive writing (unfacilitated type of TW) | Non-disclosure | ||
Sharifabad 2010105 | Written emotional disclosure (unfacilitated type of TW) | Neutral topic writing | ||
Sloan 201270 | WET | Waiting list | ||
Smyth 1999107 | Disclosure exercise (unfacilitated type of TW) | Neutral topic writing | ||
Smyth 2008121 | Expressive writing (unfacilitated type of TW) | Daily plans writing | ||
Stark 201057 | Trauma writing (unfacilitated type of TW) plus Change Theory (King type of TW) | Time management (factual writing) | ||
Tabolli 2012111 | Writing exercise (unfacilitated type of TW) | Non-writing | ||
Taylor 200389 | Written self-disclosure intervention (unfacilitated type of TW) | SMC | ||
Theadom 201058 | Written emotional disclosure (unfacilitated type of TW) | Details of previous day writing | ||
Van Dam 201392 | Expressive writing (unfacilitated type of TW) | Treatment as usual | ||
Vedhara 2007112 | Written emotional disclosure (unfacilitated type of TW) | Details of previous day writing | ||
Wagner 201073 | Expressive writing (unfacilitated type of TW) | Trivial writing | ||
Walker 199979 | Single-episode written emotional expression (unfacilitated type of TW) | Three-episode written emotional expression (unfacilitated type of TW) | Attentional control (standard care) | |
Wallander 2011109 | WSD (unfacilitated type of TW) | SMC | ||
Warner 2006108 | Written emotional disclosure (unfacilitated type of TW) | Time management | ||
Wetherell 2005117 | Emotional disclosure (writing or talking) (unfacilitated type of TW) | Time-management writing | ||
Willmott 2011104 | Written emotional expression – positive and negative (unfacilitated type of TW) | Details of previous day’s prior to heart attack | ||
Zakowski 200484 | Written emotional disclosure (unfacilitated type of TW) | Details of daily activity writing |
WSD, written self-disclosure.
Interventions definitions
TABLE 102
First author, year | Experimental condition | Control condition | |||
---|---|---|---|---|---|
Definition group 1 | Definition group 2 | Definition group 3 | Definition group 1 | Definition group 2 | |
Abel 200450 | To write about innermost thoughts related to diagnosis of HIV and living with the disease | – | – | To write about their daily activities | Inexpressive writing |
Arden-Close 201380 | To write about the patient’s diagnosis and treatment as follows: Day 1: describe the diagnosis and treatment chronologically and what led to what, without mentioning emotions Day 2: part 1, describe how you felt and what you thought at the time of the diagnosis. Part 2, what impact has your diagnosis and treatment had on your life, and has it caused you to change priorities? Day 3: how do you currently feel and think about the diagnosis and treatment? Are your current thoughts and feelings the same as at diagnosis? Would you be able to cope with similar situations better because you have experienced it? | – | – | To write about what the patient did the previous day (time management) | – |
Averill 2013100 | To write on traumatic and upsetting life experiences: Session 1: the most traumatic and upsetting experience of the patient’s life Session 2: continue writing about the topic described in session 1, or choose an alternate topic Session 3: continue writing about the topic described in session 1, or choose an alternate topic Session 4: as above, but a suggestion is made to relate experiences to subsequent life events Study measures were also completed | – | – | To complete the study measures | – |
Bartasiuniene 2011102 | Disease (self-focused): to write about their deepest thoughts and feelings related to their illness | – | – | To write about daily routine until illness | Participants in this group did not write anything but received usual care: received standard psychological care, pointed mostly for relaxation (e.g. aromatherapy, music therapy) |
Bernard 200593 | To write about the most stressful and upsetting aspects of their illness and treatment (or whatever they had reported on the IES-R, e.g. psychosis, paranoia) using a protocol adapted from Pennebaker and Beall1 | – | – | To write about different non-emotional topics (activities that day, the room they were in and plans for next week) on each day in a factual manner | – |
Broderick 2005118 | To write about any traumatic event, current or past, in their life | To write focusing more on the meaning of their past trauma | To write about day-to-day activities in relation to the time invested. Only facts should be written, excluding any emotions associated with them | Comprised viewing an educational videotape about RA [Education (ED)] | |
Broderick 2005118 | The exercise was focused on factual retelling of an important current or past traumatic event, along with emotional expression and cognitive reappraisal. The writing should involve deep thoughts and feelings about the event | – | – | To write without concern about spelling or grammar about day-to-day activities in relation to the time invested Session 1 asked for a description of plans for the past week Session 2 focused on the previous 24 hours Session 3 focused on the upcoming week It was emphasised that only facts should be written, not any emotions associated with them | – |
Canna 200694 | To write about their deepest thoughts and feelings related to their illness | – | – | Participants in this group were assigned to a non-emotional task, for which they had to describe in detail what they had done since they wake up | – |
Cepeda 200888 | To write, while at home, for at least 20 minutes, once a week, for 3 weeks, a story about how cancer affected their lives | – | – | As an attention control group, patients were asked to complete, while at home, the McGill Pain Q | Patients were asked simply to attend weekly medical follow-up visits (i.e. the same clinic schedule as the other two groups) to receive usual customary care |
Craft 201374 | To write about the deepest thoughts and feelings about breast cancer | To write about the deepest thoughts and feelings about a self-selected worst trauma | – | To write about facts of treatment only: day 1, diet; day 2, exercise; day 3, sleep pattern; day 4, medications | Non-writing |
Dennick 201484 | To write about their thoughts and feelings about any stressful experience over the last month or current concern (i.e. not specifically diabetes related) | Description of the previous day’s activities, without prompt to discuss thoughts or feelings | |||
D’Souza 2008101 | To write about a trauma or upheaval or stressful experience that you may be experiencing right now, or that you experienced at some other time in your life, particularly the most stressful that you have experienced and is the most significant to you, and ideally one that you have not talked about in detail with others. Participants were encouraged to write about the facts as well as their deepest feelings, and to try to write about the same events for all 4 writing days | – | – | To write about their activities for the past week (session 1) and past 24 hours (session 2), and their planned activities for the next 24 hours (session 3) and next week (session 4) Instructions asked participants to write only about their actions, but to refrain from writing about their feelings or opinions | – |
Gellaitry 201075 | This intervention comprises several types of expressive writing performed in a 4-day treatment Day 1: emotional disclosure – exploring deepest thoughts and feelings about your experience of breast cancer Day 2: cognitive appraisal – making sense of your illness. What does having breast cancer mean to you? Day 3: benefit finding – perceived benefits of your experience; challenges you have overcome; changed outlook on life/priorities? Day 4: looking to the future – coping strategies; sharing experience with others | – | – | – | – |
Gidron 199698 | To write about their most traumatic experiences and then in a brief predetermined format to elaborate orally on the most severe event about which they wrote | – | – | To write about their casual daily agenda without affective content and then describe daily activity orally | – |
Gillis 2006119 | Participants were asked to identify a stressful experience that continues to bother them, and they were given additional guidance on how to identify such an experience (e.g. it is difficult to think or talk about, makes them feel anxious or upset when encountering reminders of the experience or prompts intrusive thoughts). They were instructed to make the memories, images and emotions as vivid as possible, and to write both the facts and their deepest feelings about the experience. In addition, they were instructed to explore how the stressful experience has affected your FM or how you deal with having FM or you might want to explore how the experience has affected your relationships with others. Participants were encouraged to work on and resolve one stressful experience at a time, and this means that you might write about the same experience over several days or all 4 days. However, if they find that they had worked it out or feel better about one experience, they should go on and write about another stressful experience | – | – | To write about different time periods for each of the 4 writing days and to write about only their actual behaviours or planned actions rather than their feelings or opinions These four time periods were: Day 1: what they did with their time over the last week Day 2: what they did with their time over the last 24 hours DAY 3: what they plan to do with their time over the next 24 hours Day 4: what they plan to do with their time over the next week | – |
Golkaramnay 200768 | The group members met in virtual chat rooms through which they communicated through written messages. The text-based communication was synchronous and in real time | – | – | No intervention | – |
Graf 200895 | To write about the most stressful and upsetting experiences of your entire life | – | – | To write about their plans for the rest of today for 20 minutes. You may or may not want to discuss your writing or the themes of your writing with your therapist. This is your choice. Your writing will be kept completely confidential. Do not worry about spelling, sentence structure, or grammar | – |
Graham 200851 | Before writing each letter, intervention group participants completed a short exercise designed to focus their attention on existing anger related to their pain experience. In this brief questionnaire, participants were asked to consider if they currently or recently felt anger towards a health-care provider, themselves, or someone or something else and, if so, to remember and/or focus on it. Participants were given a writing tablet and instructions to write a letter to the person at whom or thing at which they were most angry. They were instructed to focus on their anger rather than other emotions | – | – | Participants in the control group did not complete the short anger-focusing exercise and were instructed to write a letter to a person of their choosing, describing their plans for the upcoming day. They were instructed to write about their goals in detail but without discussing any of their thoughts and feelings. Control group participants believed they were providing information about what they were able to do in a given day | – |
Grasing 201090 | The writing task focused on traumatic and upsetting life experiences Session 1: the most traumatic and upsetting experience of the patient’s life Session 2: continue writing about the topic described in session 1, or choose an alternative topic Session 3: continue writing about the topic described in session 1, or choose an alternative topic Session 4: as above, but a suggestion is made to relate experiences to subsequent life events | – | – | The time-management task emphasised objective, factual events. Time-management control group wrote about how time was spent during the previous day; current day (prior to the session); during the remainder of the current day (after the session); during the upcoming week | – |
Halpert 201052 | To write about the thoughts and feelings about IBS. They had to really let go, and explore the very deep emotions and thoughts | – | – | Participants who intended to write but did not start writing were offered the option to remain in the study and complete the follow-up questionnaires without writing formed the non-writing group | – |
Harris 2005106 | Trauma writing described as writing about stressful of traumatic experiences | To write about positive experiences such as events that stimulated feelings of happiness or joy | To write on neutral topics focused on the events of the previous day (control group) | – | |
Hamilton-West 2007114 | To write about any stressful experiences encountered over the last month, or any worries or concerns that are currently troubling you These might be related to the AS or not | – | – | To write in detail about the plans for the following day. Participants were permitted to write about one topic only, or move from one topic to another | – |
Henry 201053 | To write about positive thoughts and feelings regarding their experience with breast cancer | – | – | Participants did not write, just received treatment as usual | – |
Hevey 2012103 | They were asked to write about their thoughts and feelings in relation to having had a heart attack | – | – | To described daily activities in the year prior to their heart attack | – |
Hong 201167 | Music therapy programme, using songwriting-related activities consisted of three stages: Stage 1: preparing songwriting for finding preferred songs Stage 2: doing songwriting Stage 3: reinforcing songwriting | – | – | Free time was given to the participants allocated to the control group for the 16 weeks the intervention took place. Subjects just underwent the usual daily life at the nursing home | – |
Hughes 200754 | To write about their very deepest thoughts and feelings about [their] cancer and cancer treatment | – | – | Participants were given general health information typically offered to patients by their health-care providers, and was considered a treatment as usual control | – |
Ironson 201371 | To write about their worst trauma/current conflicts and then to write about what they did and future plans | – | – | To write about daily events | – |
Jensen-Johansen 201376 | To write about a traumatic or distressing event and to explore their deepest feelings and emotions associated with this experience. They were free to write about their breast cancer as well as non-cancer experiences, and to switch topics during the intervention | – | – | To write as objectively and as detailed as possible in an emotionally neutral manner about their daily activities | – |
Krpan 201396 | To write about their deepest thoughts and feelings about an extremely important emotional issue that had affected them and their life | – | – | How they organised their day | |
Kraaij 201055 | To describe their deepest thoughts and feelings regarding their HIV-positive status or any other emotionally significant topic. Participants were instructed to pay special attention to issues that they had not previously disclosed to others. All writing assignments were completed through a website that was especially designed for the present study | The self-help programme consisted of a workbook, a work programme and a CD-ROM. In the first week, participants were asked to do mindfulness-based relaxation exercises, and to continue these exercises in the following 3 weeks. In the second and third week, participants learned to identify and change irrational cognitions and to practise counterconditioning. In the fourth week, they were guided to formulate a realistic, concrete goal and to improve their self-efficacy to reach this goal | Participants on the waiting list did not receive any intervention. They were offered the interventions after completion of the study | – | |
Lange 200369 | To stimulate self-confrontation, participants had to write in the first person and in the present tense, describing in as much detail as possible the sensory perceptions that they experienced at the time of the traumatic event, including olfactory, visual and auditory sensations | – | – | For ethical reasons, the participants in the control condition were not kept waiting until the treatment group had completed the follow-up. They received treatment directly after the treatment group had terminated treatment | – |
Lumley 2011115 | To write (or speak) in a journal about this stressful experience, incorporating both facts and deepest feelings | To write (or speak) about positive emotional events in their lives, including both facts and feelings, and to describe their memories as vividly as possible | – | To write (or speak) about their daily activities over four different time intervals: day 1, the previous week; day 2, the previous day; day 3, their plans for the next day; day 4, their plans for the next week Time-management type of control | – |
Lumley 2014116 | To identify a stressful or traumatic experience that continued to cause them stress and to write about their most vivid memories and innermost thoughts and feelings about that experience. Also about finding meaning from it and anything they had learned, and how they coped with it now | Coping skills training | How they spent and managed their time over the previous week, including eating, physical activity and sleep | Arthritis education | |
Mann 200172 | To write about a somewhat positive future To write in journals nor were told to imagine an optimistic future in which they would only have to take one pill per day for HIV | – | – | Participants did not write nor were told to imagine an optimistic future in which they would only have to take one pill per day for HIV. However, efforts were made to equalise the amount of time that researchers spent with participants in the two conditions | – |
McElligott 200687 | To write about their deepest thoughts and feelings related to their illness | – | – | To write about details of previous day | – |
Meshberg-Cohen 201091 | To write about personal traumatic/stressful experiences | – | – | To write on neutral topics (e.g. what they ate on the previous day, what they did since waking up yesterday) | – |
Milbury 201481 | To write about their deepest emotions and thoughts regarding their cancer experience with slightly different probes at each session (e.g. how the diagnosis and treatment interfere with their lives; treatment-related decision-making; and fears about the future) | – | – | To write about four neutral topics: dietary behaviours, physical activity and exercise behaviours, attitudes towards smoking and other substance use, and sleep habits | – |
Mosher 201277 | Writing about their deepest thoughts and feelings regarding their cancer | – | – | To describe yesterday’s activities in a factual manner | – |
Paradisi 2010110 | To describe the worst experience in their lives related to their disease. After each writing session patients were directed to phototherapy | To write about their best possible future self and life goals. After each writing session patients were directed to phototherapy | – | Non-emotional control group. No definition given | – |
Park 201278 | Express with writing about cancer-related emotion in 20 minutes | – | No intervention | – | |
Pauley 201182 | To write about any aspect of their cancer that they would characterise as positive | To indicate what was negative about their experience | – | To write about the events of the day, the layout of their homes, or the responsibilities at their current position | – |
Petrie 200456 | To write about the most traumatic and emotional experiences of their lives, about deepest thoughts and feelings about an event that they had not previously discussed with others. They could write about HIV-related topics or any other issues of emotional importance to them | – | – | To write about how they used their time, but with slightly different orientations each day: what they had done in the previous 24 hours, and what their plans were for the next 24 hours, the next week, and the next 12 months. They were encouraged to write in a purely descriptive and objective way with minimum expression of emotions | – |
Richards 200097 | To write about the deepest thoughts and feelings, regarding an experience that had not been previously shared with others at all or in very little detail | – | – | To write about an assigned topic usually on how they manage their time | Participants were asked to go about their daily routine |
Rickett 201166 | Workshop series in two groups, split in first and second (control group) workshop times. Participants in group 1 undertook the first poetry writing programme, while the remaining participants in group 2 undertook the second During each meeting, participants read poetry selections, discussed aspects of poetry writing, wrote poems and read them aloud to the group | – | – | The second group was wait-listed to enable comparison with the first group in the workshop | – |
Rini 201486 | To explore their deepest emotions and emotions about the time before, during and after transplant and then any aspect of their transplant | Peer helping | Expressive helping | They wrote a factual account of their experience before, during and after their transplant | |
Robinson 200899 | Participants were assigned an e-mail therapist. eBT was administered by a team of therapists of different backgrounds. The therapy included online supervision and feedback from the participants. All treatment included eliciting history; asking participants to keep a dietary and feelings diary; identifying and modifying negative automatic thoughts and other cognitive styles common in eating disorders; encouraging regular meals with adequate carbohydrate; examining relationships and aspects of the participants behaviour which might exacerbate the eating disorder; managing the ending | Participants were sent an e-mail and had to spend some time at least twice a week, writing about their difficulties and to send it to one of the authors | – | Participants were placed on a waiting list. After 3 months they were reassessed and offered either eBT or SDW by random allocation | – |
Rosenberg 200283 | To write about their experience with cancer and its treatment. They were allowed to write about other experiences in their life | – | – | Any type of writing was performed | – |
Sharifabad 2010105 | To write about their most traumatic or upsetting life experiences | – | – | To write about an assigned neutral topic, describing the specific event or object in detail without describing thoughts or feelings relating to the topic | – |
Sloan 201270 | To write about the same MVA event during each writing session, about their deepest emotions and thoughts at the time of the MVA was emphasised, as well as the importance of providing detailed information about the MVA. During the second session, they had to add information about what they were thinking or feeling as the event was happening | – | – | Participants in the waiting list were encouraged to contact the project coordinator any time if they were having problems | – |
Smyth 1999107 | To write about the most stressful experience that they had ever undergone | – | – | To describe their plans for the day (framed as a time-management exercise to reduce stress) | – |
Smyth 2008121 | To write about their traumatic experience | – | – | To write about a neutral topic: time-management control writing related to their daily plans | – |
Stark 201057 | To write about their most traumatic experience (based on Broderick et al.118). Concepts of the Change Theory were incorporated by asking also patients to write their experiences as a story with a clear beginning, middle and end, as well as incorporate their deepest thoughts and emotions regarding this event, to try to perceive themselves as survivors and attempts to find any positive results that may have occurred as a result of this traumatic experience | – | – | – | |
Tabolli 2012111 | To write longhand, continuously, about the most stressful event in their life, about the experiences with psoriasis After the intervention, participants received information and educational material on the disease and its management | – | – | Control patients received only an educational intervention: patients received information and educational materials | – |
Taylor 200389 | To write about their deepest thoughts and feelings about the most distressing experience of their entire life for a period of 20 minutes Participants were encouraged to connect their topic to relationships with others (e.g. parents, caregivers, lovers, friends, relatives) and to their past, present, or future | – | – | – | |
Theadom 201058 | To write about your very deepest thoughts and feelings about an extremely important emotional issue that has affected you and your life | - | – | Day 1: to write about exactly what you did yesterday from the time you got up until the time you went to bed Day 2: to write about what they had eaten the day before Day 3: to write about the physical activity they had undertaken the previous day | – |
Van Dam 201392 | Ten individual sessions of writing: 1. In detail about the most traumatic event(s) they had experienced. The writing had to be in the first person and in the present tense, addressing sensory experiences, painful facts thoughts and emotions experienced during the trauma 2. To write a letter of advice to a friend or loved one, imagining that they had experienced the same event. Patients were asked to give advice on how to handle the thoughts and emotions 3. Write a similar letter to themselves 4. Writing a reflective letter about the trauma and its impact on their life, and their resolutions for dealing with the trauma in future | Treatment as usual | |||
Vedhara 2007112 | To write or talk about traumatic and stressful events | – | – | To provide a factual descriptive (i.e. non-emotional) account of their activities in a specified time period (e.g. yesterday) | - |
Wagner 201073 | To write about some extremely upsetting or traumatic event that they had experienced in their life | – | – | To describe in detail, as objectively as possible (a) their plans for the remainder of the day; (b) the clothes they are wearing; (c) any particular object or event of their choosing; or (d) the contents of their closet | – |
Walker 199979 | To write about the deepest thoughts and feelings about their cancer experience (during 1 day only) | To write about the deepest thoughts and feelings about their cancer experience (during 3 separate days) | – | The attentional control received usual care and on their final day of treatment the researcher met with them to chat about plans for trips or current events not related to cancer | – |
Wallander 2011109 | WSD was administered in three 20-minute sessions: one in the clinic and two by telephone in the home (no additional information was reported) | – | – | Participants received SMC appropriate to their health status from a paediatric GI specialist. SMC for RAP generally consists of follow-up office visits and/or telephone consultations, education support, dietary instructions, as well as possible oral medication and supplements to increase dietary bulk, decreased acid or increase motility, as deemed medically appropriate by treating GI specialist | – |
Warner 2006108 | To write about past negative events, about a trauma or problem that they may be experiencing at the moment of the intervention, or that they had experienced at some other time in their life | – | – | To write privately about how you manage their time, writing about a different topic every day | – |
Wetherell 2005117 | To write about their deepest emotions and thoughts about the most upsetting experience in their life, to really let go explore their feelings and thoughts about it. If they were not able to write about it they were prompted to write about anything that had upset them significantly in the past (it had to be a new topic, never discussed) | – | – | To write or talk about one of three topics. To describe, in detail: (1) everything they had done during that day (2) were planning to do the following day or (3) during the forthcoming weekend Control patients were instructed that the description should be detailed and factual and to avoid emotion during their accounts | – |
Willmott 2011104 | To write about their thoughts and feelings in relation to having had a heart attack including any emotions (positive and negative) and thoughts about how they might cope Note that on day 3, additionally, they were encouraged to try to wrap things up by, for example, thinking about how the heart attack may affect their future and again the importance of exploring thoughts and feelings was emphasised | – | – | To describe what they usually did on a Saturday, Sunday and Monday before they experienced a heart attack (each day forming the focus of one session’s writing) They were asked to describe their activities in detail and encouraged to be as objective as possible when doing so They were told that the important thing was not to get distracted by emotions but to focus on simple descriptions of what they did, such as where they went and the things they ate | – |
Zakowski 200484 | To write continuously for 20 minutes about their deepest thoughts and feelings regarding their cancer experience | – | – | To describe in detail their daily activities in a non-emotional manner in accord with previously published procedures | – |
–, not included; CD-ROM, compact disc read-only memory; IES-R, Impact of Event Scale-Revised; McGill Pain Q, McGill Pain Questionnaire.
Interventions as evaluated by the reviewers
TABLE 103
First author, year | Experimental condition | Control condition | |||
---|---|---|---|---|---|
Intervention group 1 | Intervention group 2 | Control group 1 | Control group 2 | Facilitated intervention? Yes/No | |
Abel 200450 | Unfacilitated EW | Factual writing | No | ||
Arden-Close 201380 | Unfacilitated EW | Time-management writing | No | ||
Averill 2013100 | Unfacilitated EW | Non-writing | No | ||
Bartasiuniene 2011102 | Unfacilitated EW | Factual writing | Non-writing | No | |
Bernard 200693 | Unfacilitated EW | Factual and time-management writing | No | ||
Broderick 2004113 | Unfacilitated EW | Unfacilitated EW | Time-management writing | Attention controla | No |
Broderick 2005118 | Unfacilitated EW | Time-management writing | SMC | No | |
Canna 200694 | Unfacilitated EW | Factual writing | ? | ||
Cepeda 200885 | Unfacilitated EW | Attention controla | SMC | No | |
Craft 201374 | Unfacilitated EW | Unfacilitated EW | Factual writing | Non-writing | No |
Dennick 201488 | Unfacilitated EW | Factual writing | No | ||
D’Souza 2008101 | Unfacilitated EW | Time-management writing | No | ||
Gellaitry 201075 | Unfacilitated EW | SMC | No | ||
Gidron 199698 | Unfacilitated EW | Factual writing | No | ||
Gillis 2006119 | Unfacilitated EW | Time-management writing | No | ||
Golkaramnay 200768 | Internet chat room | No intervention | Yes | ||
Graf 200895 | Unfacilitated EW | Time-management writing | No | ||
Graham 200851 | Questionnaire plus unfacilitated EW | Factual goal writing | No | ||
Grasing 201090 | Unfacilitated EW | Time-management writing | No | ||
Halpert 201052 | Unfacilitated EW | Non-writing | No | ||
Hamilton-West 2007114 | Unfacilitated EW | Time-management writing | No | ||
Harris 2005106 | Unfacilitated EW | Positive writing | Factual writing | No | |
Henry 201053 | Positive writing | SMC | No | ||
Hevey 2012103 | Unfacilitated EW | Factual writing | No | ||
Hong 201167 | Songwriting | Waiting list | Yes | ||
Hughes 200754 | Unfacilitated EW | SMC | No | ||
Ironson 201371 | Unfacilitated EW | Factual writing | No | ||
Jensen-Johansen 201376 | Unfacilitated EW | Time-management writing | No | ||
Kraaij 201055 | Website structured writing | Waiting list | No | ||
Krpan 201396 | Unfacilitated EW | Time management writing | No | ||
Lange 200369 | Website Interapy | Waiting list | Yes | ||
Lumley 2011115 | Unfacilitated EW | Positive writing | Time-management writing | No | |
Lumley 2014116 | Unfacilitated EW | Time-management writing | No | ||
Mann 200172 | Positive writing | Non-writing | No | ||
McElligott 200687 | Unfacilitated EW | Factual writing | No | ||
Meshberg-Cohen 201091 | Unfacilitated EW | Factual writing | No | ||
Milbury 201481 | Unfacilitated EW | Factual writing | No | ||
Mosher 201277 | Unfacilitated EW | Factual writing | No | ||
Paradisi 2010110 | Unfacilitated EW | Positive writing | Non-EW | No | |
Park 201278 | Unfacilitated EW | No intervention | No | ||
Pauley 201182 | Unfacilitated EW | Positive writing | Factual writing | No | |
Petrie 200456 | Unfacilitated EW | Time-management writing | No | ||
Richards 200097 | Unfacilitated EW | Time-management writing | SMC | No | |
Rickett 201166 | Poetry writing | Waiting list | Yes | ||
Rini 201486 | Unfacilitated EW | Factual writing | No | ||
Robinson 200899 | Unfacilitated EW | Waiting list | No | ||
Rosenberg 200283 | Unfacilitated EW | Non-writing | No | ||
Sharifabad 2010105 | Unfacilitated EW | Factual writing | No | ||
Sloan 201270 | Written exposure therapy | Waiting list | Yes | ||
Smyth 1999107 | Unfacilitated EW | Time-management writing | No | ||
Smyth 2008121 | Unfacilitated EW | Time-management writing | No | ||
Stark 201057 | Unfacilitated EW (mixed writing) | Non-writing | ? | ||
Tabolli 2012111 | Unfacilitated EW | Non-writing | No | ||
Taylor 200389 | Unfacilitated EW | SMC | No | ||
Theadom 201058 | Unfacilitated EW | Factual writing | No | ||
Van Dam 201392 | Unfacilitated EW | Treatment as usual | No | ||
Vedhara 2007112 | Unfacilitated EW | Factual writing | No | ||
Wagner 201073 | Unfacilitated EW | Factual and time-management writing | No | ||
Walker 199979 | Unfacilitated EW | Positive writing | SMC | No | |
Wallander 2011109 | Unfacilitated EW | SMC | No | ||
Warner 2006108 | Unfacilitated EW | Time-management writing | No | ||
Wetherell 2005117 | Unfacilitated EW | Time-management writing | No | ||
Willmott 2011104 | Unfacilitated EW | Factual writing | No | ||
Zakowski 200484 | Unfacilitated EW | Factual writing | No |
Unfacilitated EW, unfacilitated type of TW or an adaptation of it.
- a
This attention control group has not been considered for analysis in current systematic review given it was considered to have an active component and therefore not suitable for comparison. It would have been taken into account in the situation where the two other intervention groups had undertaken the same educational activity on top of the writing exercise.
Additional information on the interventions assessed
TABLE 104
First author, year | Funding | Financial compensationa | Method of instruction | Topic of the intervention | Number of topics | Topic change allowed | Duration (minutes) | Length | In a group | Type of writing | Collection of writings | Carer feedback |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Abel 200450 | Yes | Yes | Verbally | Disease self-focused | 1 | No | 20 | Three consecutive | NR | Handwriting | NR | NR |
Arden-Close 201380 | No | No | Telephone | Disease and treatment self-focused | 1 (with variations each day) | Yes | 20 | Three non-consecutive (over 3-week period) | No | Handwriting | Yes | NR |
Averill 2013100 | Yes | No | Telephone | Disease self-focused | 1 | No | 20 | Three non-consecutive (over 1 week) | No | Handwriting | NR | No |
Bartasiuniene 2011102 | No | No | In writing | Disease self-focused | 1 | NR | 30 | Four consecutive | No | Handwriting | NR | NR |
Bernard 200693 | No | No | Telephone | Disease and treatment self-focused | 1 | No | 15 | Three non-consecutive (over 10 days) | No | Handwriting | No | Yes |
Broderick 2004113 | Yes | No | Videotape | 1. Self-selected trauma 2. Enhanced meaning self-selected trauma | 2 | No | 20 | Three consecutive | No | Handwriting | No | No |
Broderick 2005118 | Yes | Yes | Verbally | Self-selected trauma | 1 | No | 20 | Three non-consecutive (at 1-week intervals) | No | Handwriting | Yes | Yes |
Canna 200694 | Yes | No | ||||||||||
Cepeda 200885 | Yes | No | Verbally | Disease self-focused | 1 | No | 20 | Three non-consecutive (at 1-week intervals) | No | Handwriting | Yes | NR |
Craft 201374 | No | No | In writing | 1. Disease self-focused 2. Self-selected worst trauma | 2 | No | 20 | Four consecutive | No | By hand or word processor | Yes | NR |
Dennick 201488 | Part | No | In writing | Self-selected trauma | 1 | Yes | 20 | 3 days over 1 week | No | Handwriting | NR | Yes |
D’Souza 2008101 | Yes | Yes | In writing | Self-selected trauma | 1 | No | 20 | Four non-consecutive (at 2-week intervals) | No | Handwriting | Yes | NR |
Gellaitry 201075 | Yes | Disease self-focused | 2 | Yes | 20 | Four consecutive | No | Handwriting | Yes | Yes | ||
Gidron 199698 | No | No | Verbally | Self-selected trauma | 1 | No | 20 | Three consecutive | No | Handwriting and oral | NR | NR |
Gillis 2006119 | No | No | In writing | Self-selected social trauma disease self-focused | 3 | Yes | 15–20 | Four consecutive | No | Handwriting | Yes | NR |
Golkaramnay 200768 | Yes | No | In writing | Here-and-now tasks | 1 | NR | 90 | Weekly for 12–15 weeks | Yes | Word processor | Yes | Yes |
Graf 200895 | No | No | In writing | Self-selected worst trauma | 1 | No | 20 | Two sessions (2 weeks apart) | No | Handwriting | Yes | Yes |
Graham 200851 | Yes | Yes | In writing | Self-selected anger | 1 | No | 20 | Two sessions (2.5 weeks apart) | No | Word processor | Yes | NR |
Grasing 201090 | No | Yes | In writing | Self-selected trauma | 1 | Yes | 20 | Four sessions over 17 days | No | Handwriting | Yes | NR |
Halpert 201052 | No | No | In writing | Disease self-focused | 1 | Yes | 30 | Four consecutive | No | Handwriting | NR | NR |
Hamilton-West 2007114 | No | NR | In writing | Disease self-focused | 1 | Yes | 20 | Three consecutive | No | Handwriting | NR | NR |
Harris 2005106 | Yes | Yes | 1. Self-selected trauma 2. Self-selected positive experience | 1 | No | 20 | Three non-consecutive (at 1-week intervals) | No | Handwriting | Yes | NR | |
Henry 201053 | Yes | Yes | In writing | Disease, positive self-focused | 1 | No | 20 | One session | No | Handwriting | Yes | NR |
Hevey 2012103 | No | NR | In writing | Disease self-focused | 1 | No | 20 | Three consecutive | No | Handwriting | Yes | NR |
Hong 201167 | No | No | Verbally | Self-selected past experience or everyday live | > 1 | Yes | 60 | Sixteen sessions at weekly intervals | Yes | Handwriting | NR | |
Hughes 200754 | No | No | In writing | Disease self-focused | 1 | NR | 30 | Three consecutive (over a five-time period) | Handwriting | NR | Yes | |
Ironson 201371 | Yes | No | In writing | Self-selected worst trauma (or current conflicts) | 1 | Yes | 20 | Four consecutive | No | Handwriting | Yes | NR |
Kraaij 201055 | No | No | NR | Disease self-focused | 1 | Yes | 30 | Four non-consecutive (at 1-week intervals) | No | Word processor | Yes | NR |
Krpan 201396 | Yes | Yes | NR | Self-selected past trauma | 1 | NR | 20 | 3 consecutive days | NR | Handwriting | NR | NR |
Jensen-Johansen 201371 | Yes | No | Telephone | Self-selected trauma | 1 | Yes | 20 | Three non-consecutive (over a 3-week period) | No | Handwriting | Yes | NR |
Lange 200369 | Yes | No | In writing | Self-selected trauma: description of sensory perceptions including olfactory, visual and auditory sensations | 1 | NR | 45 | 10 non-consecutive (over 5 weeks at 2-week intervals) | No | Word processor | Yes | Yes |
Lumley 2011115 | Yes | Yes | Verbally and in writing | 1. Self-selected stressful event 2. Self-selected positive event | 1 | No | 20 | Four consecutive | No | Handwriting | Yes | NR |
Lumley 2014116 | Yes | Yes | Verbally and in writing | Self-selected trauma | 4 | No | 20 | Four within 1 week | No | Handwriting | Yes | NR |
Mann 200172 | Yes | Yes | In writing | Self-selected positive future | 1 | NR | 10 | Four non-consecutive (twice a week) | NR | Handwriting | NR | NR |
McElligott 200687 | No | Yes | Verbally and in writing | Disease self-focused | 1 | No | NR | Three (at 1-week intervals) | No | Handwriting | No | NR |
Meshberg-Cohen 201091 | Yes | No | In writing | Self-selected trauma | 1 | NR | 20 | Four consecutive | No | Handwriting | Yes | NR |
Milbury 201481 | Yes | Yes | In writing | Disease and treatment self-focused | 1 | NR | 20 | Four non-consecutive (over 10 days) | No | Handwriting | Yes | NR |
Mosher 201277 | No | Yes | In writing | Disease (self-focused): deepest thoughts and feelings regarding their cancer | 1 | NR | 20 | Four non-consecutive (over 8 weeks) | No | Handwriting | Yes | Yes |
Paradisi 2010110 | Yes | NR | In writing | 1. Disease self-focused worst experience 2. Best possible future self and life goals | 1 | No | 20 | 3 consecutive days | No | Handwriting | No | NR |
Park 201278 | No | NR | In writing | Disease self-focused | 1 | NR | 20 | Four non-consecutive (at 1-week intervals) | Yes | Handwriting | NR | NR |
Pauley 201182 | Yes | Yes | In writing | 1. Disease, positive self-focused 2. Disease, negative self-focused | 1 | NR | 20 | 3 days (at 1-week intervals) | No | Handwriting and word processor | Yes | NR |
Petrie 200456 | Yes | NR | In writing | Self-selected worst trauma or self-focused disease | 1 | Yes | 30 | 4 consecutive days | No | Word processor | Yes | No |
Richards 200097 | Yes | Yes | In writing | Disease self-focused | 1 | NR | 20 | 3 consecutive days | No | Handwriting | Yes | NR |
Rickett 201166 | Yes | NR | In writing and verbally | Discussed aspects of poetry writing, wrote poems | 1 | NR | 120 | Weekly for 8 weeks | Yes | Handwriting | Yes | Yes |
Rini 201486 | Yes | Yes | In writing | Disease and treatment focused | 4 | No | 20 | Weekly, over 4 weeks | No | handwriting | Yes | NR. |
Robinson 200899 | No | No | In writing | Self-selected difficulties (not further specified) | 1 | NR | NR | Two sessions (over 1 week) | No | Handwriting | Yes | Yes |
Rosenberg 200283 | Yes | No | In writing | Disease and treatment self-focused | 1 | Yes | 20–30 | 4 consecutive days | No | Handwriting | NR | NR |
Sharifabad 2010105 | Yes | No | In writing and verbally | Self-selected worst experience | 1 | NR | 20 | Three sessions (at 1-week intervals) | Yes | Handwriting | NR | NR |
Sloan 201270 | Yes | Yes | In writing and verbally | Disease self-focused | 2 | Yes | 120 | Four sessions | No | Handwriting | NR | Yes |
Smyth 1999107 | Yes | Yes | In writing | Self-selected worst experience | 1 | NR | 20 | 3 consecutive days | No | Handwriting | Yes | No |
Smyth 2008121 | No | Yes | In writing | Self-selected experience | 1 | NR | 20 | Three consecutive sessions (with 15-minute rest interval between each session) | No | Handwriting | NR | NR |
Stark 201057 | No | Yes | In writing | Self-selected worst experience from a positive perspective | 1 | No | 20 | 3 consecutive days | No | Handwriting | NR | NR |
Tabolli 2012111 | Yes | No | In writing | Disease self-focused | 1 | NR | 20 | 3 consecutive days | No | Handwriting | NR | Yes |
Taylor 200389 | Yes | No | In writing | Self-selected worst experience | 1 | NR | 20 | 3 consecutive days | No | Handwriting | Yes | NR |
Theadom 201058 | Yes | No | In writing | Self-selected emotional issue | 1 | No | 20 | 3 consecutive days | No | Handwriting | Yes | Yes |
Van Dam 201392 | Yes | No | Verbally | Self-selected trauma | 4 | No | 45–60 | 10 sessions, 1 per week | No | Handwriting | Yes | Yes |
Vedhara 2007112 | Yes | No | In writing | Self-selected traumatic and stressful events | 1 | Yes | 20 | 4 consecutive days | No | Handwriting | Yes | NR |
Wagner 201073 | No | Yes | In writing | Self-selected trauma, past negative events, problem | 1 | Yes | 20 | Four non-consecutive (at 1-week intervals) | No | Word processor | Yes | NR |
Walker 199979 | No | In writing | Disease self-focused | 1 | NR | 30 | 2–3 consecutive days | No | Handwriting | Yes | NR | |
Wallander 2011109 | Yes | No | In writing and verbally | NR | NR | NR | 20 | Three sessions (in 6 days) | No | Handwriting | Yes | NR |
Warner 2006108 | Yes | Yes | In writing | Self-selected trauma | > 1 | NR | 15–20 | 3 consecutive days | No | Handwriting | Yes | Yes |
Wetherell 2005117 | Yes | No | Verbally | Self-selected most upsetting experience | 1 | NR | 20 (with so many breaks as wished) | 1 day | No | Handwriting or tape recording | Yes | Yes |
Willmott 2011104 | Yes | No | In writing | Disease self-focused | 2 | NR | 10–20 (time spent writing in each session had to be recorded) | 3 consecutive days | No | Handwriting | Yes | NR |
Zakowski 200484 | Yes | No | In writing and verbally | Disease self-focused | 1 | No | 20 | 3 consecutive days | No | Handwriting | Yes | NR |
NR, not reported.
- a
Financial compensation could be done for participation in the study or as part of the outcomes collection.
Outcomes assessed
TABLE 105
First author, year | Physiological measures | Biomarkers measures of disease progression | Patient-reported outcome measures | Resource-use measures | Adherence | Comments |
---|---|---|---|---|---|---|
Abel 200450 | Cognitive reorganisation Social stigma (stigma scale) Depression (CES-D) QoL (SF-36) | |||||
Arden-Close 201380 | Perceived stress (PSS) Intrusive thoughts (IES) QoL (FACT-General) | |||||
Averill 2013100 | Affect (ABS) Emotional approach coping (specific scale) Depression (GDS) Ambivalence over emotional expression (AEE) Social support (Social Constraints scale) QoL (McGill QOL) | |||||
Bartasiuniene 2011102 | Emotional states [PANAS-X(b)] | |||||
Bernard 200693 | Trauma of psychosis (IES-R) Recovery style (RSQ) Insight (IS) Anxiety – depression (HADS) Mood [PANAS- X(a)] | |||||
Broderick 2004118 | Disease activity (Disease Activity Rating scale) | QoL (SF-36v2 Health Survey) | ||||
Broderick 2005118 | Anxiety and depression (STAI-S, BDI-II) Physical health (FIQ, CLINHAQ) QoL (MOS-SF-36, QOL) Pain (McGill Pain Q-SF, MPI) | |||||
Canna 200694 | Anxiety (BAI, STAI) Depression (BDI-II) Distress symptoms (BSI, GSI) Panic symptoms (PSWQ) Physical symptoms (PILL) Mood (PANAS) Life satisfaction (QoLI) Social support (MSPSS) | Number of treatment sessions | ||||
Cepeda 200885 | Average pain intensity, well-being | |||||
Craft 201374 | QoL (FACT-B) | |||||
Dennick 201488 | CES-D PAID EQ-5D VAS and utility SDSCA | |||||
D’Souza 2008101 | Headache frequency, disability and severity | Physical symptoms (SCL-90-R) Immediate mood [PANAS-X(d)] Behavioural disability from headache (MIDAS) | ||||
Gellaitry 201075 | Social support (SOS) QoL (FACT-B) Mood (POMS) AEs | Number of all medical visits (scheduled and unscheduled hospital appointments, GP appointments and visits to the nurse), regardless of whether they were cancer related or not | ||||
Gidron 199698 | Physical symptoms (PILL, Mississippi scale for PTSD) Mood, depression, negative and positive affect [PANAS-X(a), IES, BDI-II] | Health-care visits [mean (SD) number of health-care visits in the last month] | ||||
Gillis 2006119 | Immediate negative mood (PANAS-X) Negative affect (NA subscale of PANAS-X) Pain (pain subscale of AIMS2) Fatigue (FSS) Social support (subscale of AIMS2) Global health status (FIQ) Physical dysfunction (AIMS2) Sleep quality (4-item scale) | Total number of visits to specialist – related or not to FM – during the last month | ||||
Golkaramnay 200768 | Patient distress (OQ-45.2) Symptomatic distress [SCL-90-R (GSI)] Subjective physical well-being (GBB) Life satisfaction (FLZ) | |||||
Graf 200895 | Mood (DASS) Functioning (OQ-45.2) | |||||
Graham 200851 | Anger expression and meaning making (expressed anger) Sadness/anxiety, depressed mood (CES-D) Pain severity (WHYMPI) Feelings of personal control over pain (SOPA) Resource use (number of years attending the centre) | |||||
Grasing 201090 | BP and heart rate (measured with patients in a sitting position) | Craving intensity (BSCS) Mood (POMS, BSI) Stress (PSS) | Total number of contacts completed outpatient mental health clinic visits for treatment of substance abuse disorders | |||
Halpert 201052 | Cognition (CG-FBD) Catastrophising/coping (CT3) IBS-specific QoL (IBS-QoL) IBS severity (IBSSS) | |||||
Hamilton-West 2007114 | Physical status – fatigue and pain mainly (BASDAI, BASFI, BAS-G) Depression (HADS) | |||||
Harris 2005106 | Lung function through spirometry (FEV1, FVC) | Adherence to probes | ||||
Henry 201053 | Depressive symptomatology (CES-D) Mood states (POMS) Physical health (Survey – 18 physical symptoms items) | |||||
Hevey 2012103 | Anxiety and depression (HADS) Coping (Brief COPE) Negative affectivity (DS-14) QoL (Mac New HRQOL) | |||||
Hong 201167 | Cognitive functioning (MMSE-K) | |||||
Hughes 200754 | Mood (PANAS) Sickness related dysfunction (SIP) Avoidant and intrusive thoughts (IES) Patient’s history of prior disclosure (DIS) | |||||
Ironson 201371 | CD4+ count (flow cytometry) and VL (quantitative reverse-transcriptase PCR) | HIV-related physical symptoms of HIV (checklist) Psychosocial distress (Davidson PTSD scale), depression (HAM-D) | Yes | |||
Jensen-Johansen 201376 | Distress (IES) Depression (BDI-SF) Negative mood (POMS) Vigour (POMS-v) Positive mood (PPMS) | |||||
Kraaij 201055 | Depressive symptoms (HADS) | |||||
Krpan 201396 | – | – | PHQ BDI | |||
Lange 200369 | Intrusions and avoidance (IES) Physical symptoms (SCL-90-R) | |||||
Lumley 2011115 | RA severity (swollen joint count, walking speed and grip strength). Physician’s global rating of disease activity (100-mm VAS) | ESR | Self-reported physical and psychological functioning (AIMS2) Affective and sensory pain (McGill Pain Q-SF) Pain behaviour (structured observation system) Immediate mood (PANAS-X) | |||
Lumley 2014116 | RA severity (swollen joint count, walking speed and grip strength). Physician’s global rating of disease activity (100-mm VAS) | Inflammation (CRP) | Self-reported physical and psychological functioning (AIMS2) Affective and sensory pain (McGill Pain Q-SF) | |||
Mann 200172 | Optimism (LOT) | Yes | ||||
McElligott 200687 | Self-esteem (ADSEI) Depression (CDI) Behavioural problems (ADSEI) Anxiety (RCMAS) Physical symptoms (PSC, PSC-Y) Physical well-being | Number of visits to the clinic and number of days in hospital | ||||
Meshberg-Cohen 201091 | Physical health problems (PILL) Distress (BSI, GSI) Depression (CES-D) Affect (PANAS-X) Drug craving (BSCS) PTSD severity (PDS) | |||||
Milbury 201481 | Fatigue (BFI) Intrusions and avoidance (IES) Psychological well-being (CES-D) Cancer-related symptoms (MDASI) Sleep disturbance (PSQI) QoL (SF-36) | |||||
Mosher 201277 | Existential well-being (FACIT-Sp) Psychological well-being (DT, HADS-A) Sleep disturbance and fatigue (PSQI, FACIT-F) | The total Global Sleep Quality score was used in this study | ||||
Paradisi 2010110 | Psoriasis severity (PASI) | QoL (Skindex-29, GHQ-12) Psoriasis severity (SAPASI) | ||||
Park 201278 | Physical symptoms (PILL, MDASI) Anxiety/depression (HADS) | |||||
Pauley 201182 | Expressiveness (ARS-20) Mental health (GHQ-12) General QoL (QLQ-30) Sexual Health and performance (specific measure) | |||||
Petrie 200456 | HIV VL (quantitative reverse-transcriptase PCR); CD4+ count (flow cytometry) | Perceived stress (PSS) Self-rated health status | ||||
Richards 200097 | Symptom and emotion self-report survey Somatic and cognitive anxiety (CSAQ) Frequency of physical symptoms (PILL) | |||||
Rickett 201166 | Non-specific emotional distress (K-10) | |||||
Rini 201486 | Relapse Mortality | |||||
Robinson 200899 | Eating disorder diagnosis (QEDD) Desired weight (BMI) Bulimia test (BITE) | Depression (BDI) | ||||
Rosenberg 200283 | Immune function/disease markers (PSA levels, peripheral blood T-cell proliferation) Serum cytokine levels of TNF-α. IL-4 and IL-10 | Health-care utilisation (NMCUES) Pain (BPI) Health-related functioning and QoL (MOS-SF-36, FACT) Psychological symptoms (SCL-90-R; Brief POMS) Rumination (Rumination scale) Coping (The Ways of Coping-Cancer Version) | ||||
Sharifabad 2010105 | Exercise capacity (6MWD), lung function through spirometry (FEV1, FVC) | QoL (CRQ) Impact on overall health, daily life and perceived well-being (SGRQ) Subjective feeling of shortness of breath (MMRC dyspnoea scale) | ||||
Sloan 201270 | PTSD diagnostic status (CAPS) Self-reported emotion (SAM) Prior trauma exposure (TLEQ) | |||||
Smyth 1999107 | Lung function through spirometry (FEV1), disease severity (DAS) | |||||
Smyth 2008121 | Cortisol (saliva sample) | Mood (POMS) Positive changes (PTGI) PTSD symptoms (PSS-I) | ||||
Stark 201057 | Affect (POMS) Chronic pain experience (MPI) Pain distress (SLESQ) Pain Catastrophising Scale Pain intensity/severity (DDS) Depression (BDI-SF) Mood/affect (POMS) | Number of health centre visits missed Quantity of pain medications taken per month Quantity of psychotropic medication taken per month | ||||
Tabolli 2012111 | Psoriasis clinical severity (PASI) | Symptoms and emotions (Skindex-29 Symptoms and Emotions scales) General health (GHQ-12, SF-36) Psoriasis severity (SAPASI) | ||||
Taylor 200389 | Health status (FEV1, BMI) | Perceived symptoms (PHQ) Physical complaints (SLESQ), physical, mental health and perceived health status (SF-12) Feasibility and acceptability of the intervention (VSQ) | ||||
Theadom 201058 | Lung function through spirometry (FEV1, FVC) | Asthma-specific QoL instrument (Marks, SSQ Asthma, SSQ Awakenings) Asthma control (ACT) Asthma distress (ABP) Beta-agonist use Corticosteroids use | Number of visits to the clinician (%) | |||
Van Dam 201392 | PDS Number of abstinent days | |||||
Vedhara 2007112 | Psoriasis clinical severity (PASI) | Skin condition consequences in QoL (DLQI) Mood (POMS, HADS) | ||||
Wagner 201073 | Affect [PANAS-X(a)] Stress (PSS) Optimism (HIV-OS) Coherence (SOC) HIV – QoL (MOS-HIV) | |||||
Walker 199979 | Affect [PANAS-X(a)] Intrusive thoughts and avoidance (IES) | |||||
Wallander 2011109 | GI pain frequency (the Abdominal Pain Frequency Rating) Somatisation severity (the Children’s Somatisation Inventory) QoL (PedsQL) | GI clinic outpatient visit | ||||
Warner 2006108 | Lung function through spirometry (FEV1) | Asthma symptoms (ASS) Affect [PANAS-X(c)] Behavioural disability (FDI) Internalising behaviour problems (CBCL) | Adherence rate to the writing assignments | |||
Wetherell 2005117 | RA severity (swollen and tender joint count), physician global rating of disease activity (100-mm VAS) Disease activity (DAS) | ESR, CRP | Mood (POMS-SF) | |||
Willmott 2011104 | Cardiac symptoms (SBP and DBP) | QoL (MOS-SF-36) | GP and attendance at cardiac rehabilitation sessions | Adherence to writing instructions | ||
Zakowski 200484 | Personality factors (NEO-FFI) Distress symptoms (BSI, GSI) Intrusive thoughts and avoidance (IES) Positive and negative moods (POMS-SV) |
6MWD, 6 Minutes’ Walk Distance; ABP, Asthma Bother Profile; ABS, Affects Balance Scale; ACT, Asthma Control Test; ADSEI, Adult version of the Coopersmith Self-Esteem Inventory; AE, adverse event; ARS-20, Assertiveness/Responsiveness scale; ASS, Asthma Sum Scale; BAS-G, Bath Ankylosing Spondylitis Disease Global Score; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BITE, Bulimia Investigatory Test Edinburgh; BMI, body mass index; Brief COPE, Brief Coping Inventory; BSCS, Brief Substance Craving Scale; CAPS, Clinician-Administered Post-traumatic Stress Disorder Scale; CLINHAQ, Clinical Health Assessment Questionnaire; CRQ, Chronic Respiratory Disease Questionnaire; CT3, catastrophising (maladaptive coping); DASS, Depression Anxiety Stress Scales; DBP, diastolic blood pressure; DDS, Descriptor Differential Scale; DIS, Perception of Disclosure scale; DLQI, Dermatology Life Quality Index; DS-14, Type D scale-14; FACIT-Sp, Functional Assessment of Chronic Illness Therapy, meaning/peace subscale; FACT-General, Functional Assessment of Cancer Therapy Questionnaire–General; FDI, Functional Disability Inventory; FIQ, Fibromyalgia Impact Questionnaire; FLZ, Fragebogen zur Erfassund des Lebenszufriendenheit (Life Satisfaction Scale); FSS, Fatigue Severity Scale; IBS-QoL, Irritable Bowel Syndrome Quality of Life; IES-R, Impact of Event Scale-Revised; IL-4, interleukin 4; IL-10 interleukin 10; IS, Insight Scale; LOT, Life Orientation Test; Mac New HRQOL, Mac New Health Related Quality Of Life scale; Marks, Marks Asthma Quality of Life Questionnaire; McGill Pain Q-SF, McGill Pain Questionnaire-Short Form; McGill QOL, McGill Quality Of Life; MIDAS, Migraine Disability Assessment Scale; MMRC, Modified Medical Research Council, dyspnoea scale; MMSE-K, Mini Mental State Examination Korean Version; MOS-HIV, Medical Outcomes Study HIV Health Survey; MSPSS, Multidimensional Scale of Perceived Social Support; NA, not applicable; NEO-FFI, NEO-Five Factor Inventory; NMCUES, National Medical Care Utilisation Expenditure Survey; PAID, Problem Areas in Diabetes scale; PANAS-X, Positive and Negative Affect Schedule – Expanded Form; PANAS-X(a), Positive and Negative Affect Schedule; PANAS-X(b), Positive and Negative Affect Schedule – Expanded Form; PANAS-X(c), Positive and Negative Affect Schedule for Children; PANAS-X(d), Positive and Negative Affect Schedule – Abbreviated version of the expanded version; PAS, Posttraumatic Stress Diagnostic Scale; PCR, polymerase chain reaction; PDS, Posttraumatic Stress Diagnostic Scale; PedsQL, Paediatric Quality of Life; PHQ, Patient Health Questionnaire; POMS-SV, Profile of Mood States Short Version; POMS-v, Profile of Mood States vigour subscale; PSC, Paediatric Symptom Checklist; PSC-Y, Paediatric Symptom Checklist Youth Report; PSS-I, Post-Traumatic Stress Disorder Symptom Scale Interview; PTGI, Post-Traumatic Growth Inventory; QLQ-30, Quality of Life Questionnaire; QOL, Quality of Life Scale; QoLI, Quality of Life Inventory; RSQ, Recovery Style Questionnaire; SAM, Self-Assessment Manikin; SBP, systolic blood pressure; SDSCA, Summary of Diabetes Self-Care Activities scale; SF-12, Short Form questionnaire-12 items (brief version of the SF-36); SF-36v2, Short Form questionnaire-36 items, version 2; SGRQ, St George’s Respiratory Questionnaire; SIP, Sickness Impact Profile; SLESQ, Stressful Life Events Screening Scale; SOPA, Survey Of Pain Attitudes; SSQ Asthma, Wasserfallen Symptom Score Questionnaire, asthma subscale; SSQ Awakenings, Wasserfallen Symptom Score Questionnaire, awakenings subscale; STAI-S, State/Trait Anxiety Scale, state subscale; TLEQ, Trauma Life Experience Questionnaire; VAS, visual analogue scale; WHYMPI, West Haven-Yale Multidimensional Pain Inventory.
Outcomes measures definitions
TABLE 106
Acronym | Definitions given in the primary studies | Scale and scoring | Meaning |
---|---|---|---|
6MWD | Changes in 6 Minutes’ Walk Distance (6MWD) over the study period | Values are given in metres | The longer the distance in the 6MWD, the higher the performance |
ABP | The Asthma Bother Profile (ABP) is a 23-item self-administered questionnaire (Hyland et al.162) designed to measure level of distress caused by asthma. It covers two domains: distress and asthma management measured with a unidimensional scale | 6-point Likert scale with 0 (no) and 5 (yes); with use of 0–5 scale. All scores are added up with a maximum of 75 and minimum of 0 | Higher scores indicate higher distress caused by asthma |
ABS | The Affects Balance Scale (ABS; Bradburn163) is a self-reported measure, which rates the degree to which participants experienced 20 positive and 20 negative emotions during the past week through two subscales: Positive Affect Scale (PAS) and Negative Affect Scale (NAS). It is a 10-item outcome measure: it contains five statements reflecting positive feelings and five statements reflecting negative feelings | An affect balance score is calculated based on the difference between the number of yes responses to positive-feeling questions minus the number of yes responses to negative-feeling questions | The greater the score difference, the higher the affect unbalance |
Abdominal pain frequency | Stomach pain frequency was rated when it was sufficiently bad not to pursue with normal activity | From 0 to 5 With 0 (not at all), 1 (once), 2 (once a week), 3 (about two or three times a week), 4 (about every other day), 5 (every day) | Higher scores indicate more frequency of abdominal pain |
ACT | The Asthma Control Test (ACT), a five-question survey (with 4-week recall) on symptoms and daily functioning, which is self-administered by the patient to measure asthma control in individuals of ≥ 12 years. The survey measures the elements of asthma control as defined by the National Heart, Lung, and Blood Institute: frequency of shortness of breath and general asthma symptoms, use of rescue medications, the effect of asthma on daily functioning, and overall self-assessment of asthma control. ACT is clinically validated by specialist assessment and spirometry (www.thoracic.org/assemblies/srn/questionaires/act.php) | 5-point scale for symptoms and activities from 1 (all the time) to 5 (not at all); for asthma control rating from 1 (not controlled at all) to 5 (completely controlled). The scores range from 5 (poor control of asthma) to 25 (complete control of asthma) | Higher scores reflecting greater asthma control. An ACT score of > 19 indicates well-controlled asthma |
Adherence | Self-reported adherence in the study by Mann72 was measured using the general measure of adherence from the RAND Medical Outcomes Study. It consists of five items | 6-point Likert scale ranging from 1 (none of the time) to 6 (all of the time) | NA |
ADSEI | An adult version (Ryden164) of the Coopersmith Self-Esteem Inventory (SEI; Coopersmith165): test–retest reliability and social desirability The Coopersmith Self-Esteem Inventory (SEI): 58 short statements that are answered by checking the box like me or unlike me. These items consist of 50 self-esteem items and eight items that compose a lie scale, anxiety, depression, behavioural problems and physical well-being | The test has a built-in lie scale that helps to determine if the participant is trying too hard to appear to have high self-esteem | The higher the number of like me, the greater the participant’s self-reports are markedly influenced by the social desirability factor |
AEE | The Ambivalence Emotional Expression (AEE; King and Emmons166) Questionnaire is a 28-item questionnaire used to assess the extent to which participants feel uncomfortable or regret expressing their emotions (e.g. I’d like to talk about my problems with others but at times I just cannot, I feel guilty after I have expressed anger to someone) | The test predicts more benefit from disclosure | NA |
AIMS2 | The Arthritis Impact Measurement Scale-2 (AIMS2) is a 28-item scale that surveys the effects of arthritis on multiple domains of functioning during the previous month. It uses six subscales: mobility level (e.g. you were in bed or chair for most of the day), walking and bending (e.g. you had trouble either bending, lifting, or stooping), hand and finger function, arm function, self-care tasks, and household tasks. In the study by Lumley et al.115 they analyse two scales: (1) physical dysfunction, which assesses dysfunction in mobility, walking/bending, hand and finger function, arm functioning, ability to perform household tasks, and self-care; and (2) affective disturbance, which assesses both anxious and depressive symptoms | 5-point scale with respect to the frequency (number of days in a week) that a particular behaviour or symptom was experienced from 1 (all days) to 5 (no days). Ratings are averaged | Higher scores indicate greater dysfunction |
AIMS2: lack of social support subscale | The 4-item subscale from the AIMS2 assesses one’s perceptions that family and friends are available if needed, are sensitive to needs, interested in helping, and understand the effects of the FM. Items were rated regarding how frequently support is available | From 1 (all days) to 5 (no days) and averaged | Higher values indicate less social support |
AIMS2: pain subscale | The 5-item pain subscale from the AIMS2, a widely-used instrument that measures health status in rheumatic diseases during the past month. Items were worded for FM rather than arthritis (e.g. you had severe pain from your FM) | 5-point scale from 1 (all days) to 5 (no days), reverse scored and averaged | Higher values indicate more pain |
AIMS2 for physical dysfunction | The AIMS2 was used and assessed 28 items from six subscales: mobility level (you were in bed or chair for most of the day), walking and bending (you had trouble either bending, lifting, or stooping), hand and finger function, arm function, self-care tasks and household tasks | 5-point scale from 1 (all days) to 5 (no days) and scored | Higher scores indicate greater physical dysfunction |
ARS-20 | The Assertiveness/Responsiveness scale (ARS-20; Richmond and McCroskey167) is a 20-item scale consisting of two subscales, one for each trait, with 10 items each | Both scales ask respondents to rate how much they identify with a list of representative behaviours. Behaviours for the Assertiveness scale include items like defend own beliefs and have strong personality, whereas items from the Responsiveness scale include items such as sympathetic and sensitive to the needs of others | Higher scores indicate greater levels |
ASS | The Asthma Sum Scale (ASS) is a 9-item scale used to report both asthma and nasal or allergy symptoms during the past 2 weeks | 5-point scale from 0 (none) to 4 (severe) | Higher scores indicate greater symptoms |
BA use | Beta-agonist use, measured as puffs per day | Numbers of puffs per day were summed up | Higher number of puffs indicated greater symptoms |
BAI | The Beck Anxiety Inventory (BAI; Beck and Steer168) is a 21-item self-report measure that uses a 4-point Likert scale with ratings from not at all to severely to measure physical and cognitive symptoms of anxiety | Each BAI item is rated on a 4-point scale: 0 (not at all) to 3 (severely, I could barely stand it) | Higher total scores indicate more severe anxiety symptoms |
BAS-G | The Bath Ankylosing Spondylitis Disease Global Score (BAS-G; Jones et al.169) requires patients to respond to two questions regarding the effect of their disease on their health: over the past week, and over the past 6 months. Responses to these scales are indicated by marking a line on a 100-mm VAS | Scale 0–10 VAS, best 10 Total score range from 0 to 10 | Higher scores indicate greater effect of AS on the patient’s life |
BASDAI | The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) comprises six questions relating to individual domains of fatigue, spinal pain, joint pain and symptoms, together with perception of pain relating to bony areas of the body and to morning stiffness BASFI comprises 10 questions regarding function in AS and ability to meet the physical demands of everyday life. Responses to these scales are indicated by marking a line on a 100-mm VAS | Scale 0–10 VAS, best 10 Total score ranges from 0 to 10 | Higher scores indicate higher levels of disease activity |
BASFI | The Bath Ankylosing Spondylitis Disease Functional Index (BASFI; Calin et al.170). Responses to these scales are indicated by marking a line on a 100-mm VAS | Scale 0–10 VAS, best 10 Total score range from 0 to 10 | Higher scores indicate to greater limitation of function |
BDI | The Beck Depression Inventory (BDI; Beck et al.171). The full BDI has 21 items, which stress cognitive symptoms of depression, each with four Guttman-type responses choices in the form of statements, ranked in order of severity. In some categories, two alternative statements are assigned the same score | Scale 0–3, reflecting severity Total scores range from 0 to 63 | Higher total scores indicate more severe depressive symptoms |
BDI-II | The revised Beck Depression Inventory (BDI-II; Beck et al.172) is a 21-item self-report measure incorporating cognitive, affective and somatic aspects of depressed mood. In this revised version, there is one alternative score for each level (so no statement is assigned the same weight) | Four alternatives for the 21 items ranging from 0 (low) to 3 (high). Total scores range from 0 to 63 | Higher total scores indicate more severe depressive symptoms |
BDI-SF | The short 13-item version of Beck Depression Inventory (BDI-SF; Beck et al.173 and Furlanetto et al.174) measures depressive symptoms during the last 7 days | NA | Higher total scores indicate more severe depressive symptoms |
BFI | The Brief Fatigue Inventory (BFI; Mendoza et al.175) is a 10-item questionnaire asking participants to rate the severity of their fatigue and the degree to which it interferes with their lives. BFI has been specifically developed for cancer patient populations | Response to the first question, ‘Are you usually tired?’ is either yes or no. The remaining nine items are measured on a 11-point Likert scale ranging from 0 (no fatigue) to 10 (worst that you can even imagine). Individual scores are added up in a total score | Higher scores indicate worse fatigue, and a score of > 3 indicates clinically significant fatigue |
BITE | The Bulimia Investigatory Test Edinburgh (BITE; Henderson and Freeman176). This 33-item scale provides a rating of symptoms of BN and BED, and has a symptom and severity subscale. BITE was used to measure symptoms over the past month, as a response to treatment. The symptom scale comprised 27 items and the severity scale comprised three items |
|
|
BMI | In the study by Taylor et al.,89 the body mass index (BMI) was recorded as kg body weight (kg)/height (m2) | NA | A reduction in the BMI indicated disease progression and/or exacerbation |
BPI | The Brief Pain Inventory (BPI), short form, is a 11-item self-report rating scale using simple numeric rating scales to assess the severity of pain (four questions) and impact of pain (seven questions) | From 0 to 10 | Higher scores indicate greater pain |
Brief COPE | The Brief COPE is a 28-item measure of 14 coping responses (Carver177). The responses can be categorised as adaptive coping (e.g. active coping, planning, use of emotional support) and maladaptive coping (e.g. denial, self-blame and behavioural disengagement) | 5-point Likert scale ranging from 1 (I haven’t been doing this at all) to 5 (I have been doing this a lot) Items are calculated into 14 separate indices | Higher scores indicate greater active coping |
Brief POMS | The Brief Profile of Mood States (Brief POMS) provides a summary measure of distress or mood. The original 65-item POMS has been widely used with cancer patients | 5-point Likert scale ranging from 0 (not at all); 1 (a little); 2 (moderately); 3 (quite a bit); 4 (extremely) | Higher scores indicate higher distress |
BSCS | The Brief Substance Craving Scale (BSCS) is a 12-item self-report instrument assessing intensity, frequency and length of craving over a 24-hour period for substances of abuse. Each of the three items is related to the intensity, frequency and length of craving during the prior 24 hours. In Grasing et al.,90 the reductions in craving intensity were measured and those are calculated by subtracting baseline measures recorded during screening from results obtained at the initial outpatient visit | 5-point Likert scale ranging from 0 (not at all) to 4 (extremely). The total score ranges from 0 to 12 | Higher scores indicate higher craving |
BSI | The Brief Symptom Inventory (BSI; Derogatis and Melisaratos178) is a 53-item scale, a shortened version of the SCL-90 (Symptom Checklist-90) that assesses nine symptoms of distress and provides three global distress indices. The BSI measures symptoms associated with distress on nine symptom dimensions (including somatisation, obsessive–compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation and psychoticism). Participants report the extent to which they experienced each of the symptoms in the past week including today. The scale also includes a global index of distress, the Global Severity Index (GSI) used in both studies by Zakowski et al. published in 200484 and 2011161 | Likert-type scale ranging from 0 (not at all) to 4 (extremely) | Higher scores indicate higher symptoms |
C-QoL | Cancer Quality of Life (C-QoL; Lee179) is a cancer-specific type of QoL measurement tool developed in Korea to better reflect the cultural characteristics of the country. The C-QoL was used in Park and Yi78 and consists of 21 items with specific questions: physical conditions (n = 6), emotional states (n = 6), social role (n = 3), social status (n = 3) and coping ability (n = 4) | 5-point scale (0 = not at all, 1 = a little yes, 2 = moderate, 3 = quite a lot and 4 = very much so) Range from 0 to 84 | Higher scores indicate greater QoL |
CAPS | The Clinician-Administered PTSD Scale (CAPS; Weathers et al.180) used to assess PTSD symptom severity. CAPS rates the frequency and intensity of each symptom along 5-point ordinal scales, the impact of symptoms on the patient’s social and occupational functioning, the overall severity of the symptom complex, and the global validity of ratings obtained. There is a total score for the CAPS PTSD ratings (frequency and intensity). The CAPS yields both dichotomous (i.e. present or absent) and continuous (i.e. severity) scores for each symptom and for the disorder as a whole | 5-point scale ranging from 0 to 136 | Higher scores indicate greater severity of PTSD symptoms |
CBCL | The Child Behavior Checklist (CBCL) and by youth on the Youth Self-Report of the CBCL (Achenbach181) consists of 113 questions used to detect emotional and behavioural problems in children and adolescents | 3-point Likert scale ranging from 0 (absent), 1 (occurs sometimes), 2 (occurs often) | Higher scores indicate more emotional and behavioural problems |
CD4+ count | CD4+ lymphocyte count was determined by flow cytometry. A square root transformation was used on the CD4+ counts to give an approximately normal distribution. Data were analysed as a multivariate hierarchical model using the hierarchical linear modelling programme HLM 5.04. In Ironson et al.,71 flow cytometry was performed in one laboratory to enumerate CD3+/CD4+ lymphocytes with fluorochrome conjugated monoclonal antibodies in a four-colour system | Threshold used in the study was not reported but used as a predictor of disease progression | Higher count in CD4+ cells when associated with improved immune status and better health |
CDI | The Children Depression Inventory (CDI) contains 27 items that represent a range of depressive symptoms including disturbed mood, hedonic capacity, vegetative functions, self-evaluation and interpersonal problems. The child is asked to choose the item that best describes him or her for the past 2 weeks. The five factors for the CDI are negative mood, interpersonal problems, ineffectiveness, anhedonia and negative self-esteem | Each item consists of three statements that are keyed 0, 1 or 2 | Higher scores indicating increased severity |
CES-D | The Centre for Epidemiological Studies Depression Scale (CES-D; Radloff182) is a 20-item scale; participants rated the intensity and frequency of depressive symptoms they had experienced in the past week. The CES-D has been used to measure clinical and subclinical levels of depression in medical populations and effectively identifies depression among patients with chronic pain (Geisser et al.183). It includes four factors: dysphoria, positive affect, a somatic factor, and an interpersonal factor. In Henry et al.,53 four subscales were calculated from the CES-D: depressed mood (seven items, α = 0.83–0.92), (lack of) positive affect (four items, α = 0.71–0.9), somatisation or retarded activity (seven items, α = 0.5–0.9), and (lack of) interpersonal relations (two items) | 4-point Likert-type scale from 0 (rarely or none of the time) to 3 (most or all of the time) | Higher scores indicates the greatest frequency of depressed mood over the past week |
CG-FBD | The functional bowel disease-related cognition consisted of CG-FBD Q16 My bowel symptoms make me feel out of control and CG-FBD Q31 Nothing seems to help my bowel symptoms | Scale 0–7, worse cognition 7 | Higher scores indicate worse adaptive cognition |
CLINHAQ | Three items from the Clinical Health Assessment Questionnaire (CLINHAQ; Wolfe184) were used in Broderick et al.118 to assess GI, headache and fatigue symptoms. The CLINHAQ contains self-reports for the Health Assessment Questionnaire (HAQ; Fries185) disability index, Arthritis Impact Measurement Scale (AIMS) anxiety and depression index (Hawley and Wolfe186), VAS pain, VAS global severity, VAS GI symptoms, VAS sleep problems, VAS fatigue, satisfaction with health, and patient estimate of health status. In 1996, the helplessness subscale of the RAI was added to the CLINHAQ (deVellis et al.187). The variables contained in this questionnaire consider factors that are thought to be of major importance in FM (Burckhardt et al.188) | On a 100-point VAS | Higher scales indicate greater symptoms |
Cortisol | Cortisol reactivity was assessed in Smyth et al.9 by asking participants to collect saliva by placing a sterile cotton wad in their mouth for a few minutes and then sealing the cotton in a salivette, a test tube-like container (Sartstedt, Rommelsdorf, Germany). Samples were kept frozen until shipped for assay at a clinical laboratory | Cortisol levels were assessed in response to imagery-based trauma re-exposure | Lower levels indicate greater health improvement |
CRP | The C-reactive protein (CRP), which is another serum measure of inflammation, was measured in Wetherell et al.117 CRP is an acute phase protein, levels of which fluctuate over a shorter time period than ESR (Kushner189). CRP therefore provides an objective marker of disease activity in addition to the components of the DAS | CRP is a measure of inflammation and provide markers for clinical status in rheumatic disease. CRP is sensitive and is only raised during periods of acute inflammation | Higher CRP levels indicate greater transitory acute inflammation |
CRQ | The Chronic Respiratory Disease Questionnaire (CRQ) is an interviewer-administered questionnaire measuring both physical and emotional aspects of chronic respiratory disease. It has 20 questions in four categories: dyspnoea, fatigue, emotional function and mastery | 7-point scale, with 7 indicating no health impairment. A change of 0.5 for each is considered the minimal clinically significant change | Higher scores indicate better HRQoL |
CS use | Corticosteroid use, measured as puffs per day | CS use is an indicator of disease status | The higher the use of CS, the worst the disease course |
CSAQ | The Cognitive-Somatic Anxiety Questionnaire (CSAQ; Schwartz190) a trait anxiety inventory, is a 14-item self-report inventory that is divided into two 7-item scales (cognitive and somatic) that appear to reflect cognitive or somatic anxiety. Participants are asked to rate the degree to which they are generally or typically experiencing symptoms of anxiety by circling a number from 1 through to 5 | 5-point Likert scale ranging from 1 (not at all) to 5 (very much so). The sums of the circled rating are separately computed for the cognitive and somatic items, and constituted the main dependent measures | Higher total scores indicate higher symptoms |
CSI | The Children’s Somatisation Inventory (CSI) includes 36 symptoms from the criteria for Somatisation Disorder and the Somatisation factor of the Hopkins Symptom Checklist. Ratings are obtained on the severity with which the youth have experienced each symptom (e.g. headaches, pains in the heart, muscle aches) in the past 2 weeks | 5-point scale from 0 (not at all) to 4 (a whole lot). A total score was calculated in the standard fashion to measure severity of general somatisation symptoms | Higher scores indicate higher severity of symptoms |
CT3 | Catastrophising (maladaptive coping) | Scale 0–36; worse catastrophising, 36 | Higher scores indicate worse catastrophising |
DAS | The Disease Activity Score (DAS) involves measurement of four variables: counts of the number of swollen and tender joints (assessed by physical examination); a patient self-report measure (All things considered, how are you feeling?), measured using a 100-mm VAS; and a serum measure of inflammation, i.e. ESR. ESR is an indirect measure of acute phase reactions and provides a standardised and validated clinical index for assessing disease activity in RA (Fuchs191). A total score can be computed or individual components of the DAS can be used | The DAS ranges from 2 to 10 | Scores of < 2.6 indicate disease remission and scores of > 5.1 indicate high disease activity |
DASS | The Depression Anxiety Stress Scales (DASS) is a 42-item self-report measure used to assess depression, anxiety and stress in clinical samples over the previous week | 4-point Likert scale from 0 (did not apply to me at all) to 3 (applied to me very much, or most of the time) | Higher scores indicate greater symptoms |
Davidson PTSD scale | The Davidson PTSD scale (PTSDTOT; Davidson et al.,192 Zlotnick et al.193) is a 17-item, interview-administered measure based on the PTSD symptom clusters defined by DSM-IV. Respondents are asked to rate each of the 17 items referring to a particular traumatic event, or series of events, according to level of distress based on their ratings of symptoms that have occurred during the past week. Both frequency and severity are rated for each item. If the respondent has experienced multiple traumatic episodes, multiple copies of the scale may be administered | From 0 to 4 for both frequency and severity during the past week Items are summed for a total score, and subscales measure re-experiencing, avoidance and arousal | Higher scores indicate greater symptoms |
DBP | Diastolic blood pressure (DBP), measured in mmHg | BP is indicative of chronic complications post MI, such as cardiac arrhythmias and left ventricular failure | Higher DBP indicated greater post-MI complications |
DIS | The Perception of Disclosure Scale (DIS) measures the perception of the extent to which participants had already expressed their deepest thoughts and feelings about their cancer experience through writing or discussion with others | Scale ranges from 0 (not all) to 10 (complete disclosure) | Higher scores indicate more complete disclosure |
Disease Activity Rating Scale | The Disease Activity Rating Scale is a scale used by physicians to indicate the current status of the patient’s RA. Factors that physicians would take into account in making this rating include number of tender and swollen joints, and degree of inflammation and pain | 5-point rating scale ranging from 0 (asymptomatic) to 4 (very severe) A 1-point change is considered clinically significant | Higher scores indicate greater disease activity |
DLQI | The Dermatology Life Quality Index (DLQI; Finlay and Khan194) is used widely in patients with dermatological conditions, including psoriasis. It examines respondents views on the functional consequences of their skin condition on their lives in the previous week. It correlates well with clinical measures of disease severity and boasts of good reliability statistics. It measures how much the skin problem has affected your life. It is designed for young people aged > 16 years and for adults | 4-point Likert scale ranging from very much to not at all The scoring is:
| The higher the score, the more QoL is impaired |
DS-14 | The DS-14 is a 14-item measure of negative affectivity (seven items) and social inhibition (seven items) (Denollet195) The DS-14 has good psychometric properties and is widely used with cardiac populations (e.g. Denollet et al.196) | 5-point Likert scale from 0 to 4 | A score of ≥ 10 on both the negative affectivity and social inhibition scales indicates Type D personality |
DT | The Distress Thermometer (DT; Roth et al.197) assessed general distress | 11-point Likert scale from 0 (no distress) to 10 (extreme distress) | Higher scores indicate greater distress |
Emotional approach coping | In Averill et al.,100 the emotional approach coping (Stanton et al.198) was measured to assess emotional processing (four items: e.g. I take time to figure out what I am really feeling; α = 0.76) and emotional expression (four items; e.g. I feel free to express my emotions; α = 0.89). Because the two subscales were correlated only 0.61, they were used separately in analysis | 8-item scale | Lower emotional approach copying are related to lower psychological well-being |
EQ-5D | QoL measured by utility and VAS. A measure of perceived health status | Utility: 0–1, where 0 is death and 1 is perfect perceived health VAS: 0–100, where 0 is death and 100 is perfect perceived health | Higher scores indicate better health |
ESR | The erythrocyte sedimentation rate (ESR) | ESR is an indicator of inflammation and disease activity | Values of > 20 mm/hour indicate elevated inflammation and disease activity |
Expressed anger | In Graham et al.,51 the degree of express anger was uniquely accounted for intervention effects and meaning making mediated effects on depressed mood | From 0 (none) to 4 (very much) A code of 4 was given when the letter included an explicit statement indicating that the participant was, for instance, very angry or furious or if the participant had used many examples that sounded frustrating and/or used underlining, exclamation points, or other techniques for emphasis A code 0 was given when the participant neither identified at all with an anger-related emotion (including frustration) nor gave any examples that seemed frustrating | Higher scores indicate higher expression of anger |
FACIT-F | The Functional Assessment of Chronic Illness Therapy Fatigue subscale version 4 (FACIT-F; Yellen199) assessed fatigue during the past 7 days. It measures physical well-being, social/family well-being, emotional well-being, functional well-being and additional concerns | All items are measured on a 5-point Likert scale ranging from 0 (not at all) to 4 (very much) | Higher scores indicate greater fatigue |
FACIT-Sp | The meaning/peace subscale of the Functional Assessment of Chronic Illness Therapy–Spiritual Well-Being scale (FACIT-Sp; Peterman et al.200) A 12-item self-report measure comprises two subscales: one measuring a sense of meaning and peace and the other assessing the role of faith in illness A total score for spiritual well-being is produced. In Mosher et al.,77 the FACIT-Sp is used to measure existential well-being by assessing participant’s degree of purpose in life and inner peace | Scale ranging from 0 to 48 Two subscales:
| Higher scores signifying greater spiritual well-being |
FACT-General | The Functional Assessment of Cancer Therapy (FACT; Basen-Engquist et al.201) questionnaire is a 34-item general cancer QoL measure for evaluating patients receiving cancer treatment. It covers five general cancer-related domains (physical well-being, social family well-being, relationship with health-care provider, emotional well-being, and functional well-being) and one disease/site-specific domain | 5-point scale from 0 (not at all) to 4 (very much) | Higher scores indicate better QoL |
FACT-B | The Functional Assessment of Cancer Therapy-Breast Cancer Version (FACT-B) is a 37-item self-report instrument, with known validity and reliability, containing 27 general items (from the FACT-General) plus 10 breast cancer-specific items (Brady et al.202) Subscales include physical well-being (seven items), social/family well-being (seven items), emotional well-being (six items) and functional well-being (seven items) The 10 additional items address physical and psychological concerns related to breast cancer Respondents are asked to rate how true each statement had been for them over the past 7 days | 5-point Likert-type scale from 0 (not at all) to 4 (very much). All 37 items can be combined for a total QoL score, and subscale scores may be computed as well | Higher scores indicate higher QoL |
FDI | The Functional Disability Inventory (FDI; Walker and Greene203) is a 15-item assessing difficulty performing various routine behaviours during the last few weeks | Items range from 0 (no trouble) to 4 (impossible) and totalled | Higher scores indicate greater disability |
FEV1 | The forced expiratory volume in 1 second (FEV1) | FEV1 is one of the primary indicators of health status and disease progression for cystic fibrosis or patients with asthma, for instance | A decrease in FEV1 indicates disease exacerbation and/or reduction of lung functioning |
FIQ | The Fibromyalgia Impact Questionnaire (FIQ) evaluates the global health status using a 10-item survey assessing those components of health that are most affected by FM (physical functioning, work status, depression, anxiety, sleep, pain, stiffness, fatigue and well-being) during the prior week FIQ is an adaptation of the HAQ and the AIMS In Broderick et al.,118 items assessing physical functioning and stiffness were used | Scores range from 0 to 100 | Higher scores indicate poorer health or functioning |
FLZ | The Fragebogen zur Erfassung des Lebenszufriendenheit (FLZ) is a Life Satisfaction Scale used to measure life satisfaction The FLZ uses eight items assessing patient’s satisfaction with different areas of their life (e.g. social contacts, partnership, financial situation) | 7-point Likert scale from 1 (very satisfied) to 7 (very unsatisfied) The sum score indicates overall life satisfaction | Higher scores indicate less life satisfaction |
FSS | The 9-item Fatigue Severity Scale (FSS) assesses the frequency and severity of fatigues interference with physical functioning | Items were rated on a 1–7 scale and averaged | Higher scores indicate greater fatigue |
FVC | The forced vital capacity (FVC) | FVC is one of the primary indicators of health status and disease progression for cystic fibrosis or patients with asthma, for instance | A decrease in FVC indicates disease exacerbation and/or reduction of lung functioning |
GBB | The Giessener Beschwerdebogen (GBB) is a 24-item scale assessing various symptomatic complaints The sum score measures subjective physical well-being | 5-point Likert scale ranging from 0 (not applicable) to 4 (strongly) The total score ranges from 0 to 12 | Higher scores indicate greater symptoms, decreased subjective physical health |
GDS | The Geriatric Depression Scale (GDS; Yesavage et al.204) is a 30-item scale that is more appropriate for use with people with ALS than other depression instruments that include somatic symptoms regularly experienced in ALS |
| Higher scores indicate higher symptoms of depression |
GHQ-12 | The General Health Questionnaire (GHQ-12; Goldberg et al.205) was used as an indicator of overall mental health in hundreds of studies that assessed both clinical and non-clinical populations Items from the GHQ-12 included: Have you recently been able to concentrate on what you are doing? Have you been able to face up to your normal problems? Owing to the various thresholds of the GHQ-12, the mean GHQ score for a population of respondents was suggested as a rough indicator for the best cut-off point (Goldberg et al.206). Therefore, based on the mean GHQ score for this sample, the cut-off point is used to determine the respondent’s level of psychological well-being | 4-point Likert scale The scores are summed up by adding all the items on the scale ranging from 0 to 12 | NA |
GSI | The Global Severity Index (GSI) is a widely used index of stress and is highly correlated with the BSI subscales. Individuals report the extent to which they experienced each of the symptoms in the past week including today | 5-point Likert scale Ranges from 0 (not at all) to 4 (extremely) | Higher scores indicate greater severity |
HADS | The Hospital Anxiety and Depression Scale (HADS; Zigmond and Snaith207), which contains 14 items (seven anxiety items and seven depression items) This scale requires participants to indicate how they have been feeling during the past week. In Wallander et al.,109 participants with a HADS total score of 15 were classified as being clinically distressed | 4-point scale ranging from 0 (not at all) to 3 (most of the time) Total score ranges from 0 to 21 | Higher scores indicate higher anxiety/depression |
HADS-A | The anxiety subscale of the Hospital Anxiety and Depression Scale (HADS-A; Zigmond and Snaith207) | A score of 0–7 is considered to be normal Scores of ≥ 20 indicate moderate, severe or very severe anxiety | Higher scores on each individual scale or the entire scale indicate greater anxiety or mood disorder |
HADS-D | The depression subscale of the Hospital Anxiety and Depression Scale (HADS-A; Zigmond and Snaith207) | A score of 0–7 is considered to be normal Scores of ≥ 20 indicate moderate, severe or very severe depression | Higher scores on each individual scale or the entire scale indicate greater depression or mood disorder |
HAM–D | The Hamilton Depression Scale (HAM–D; Hamilton208) is a 17-item, interview-based measure, considered the gold standard for assessing severity of depression | A score of 0–7 is considered to be normal Scores of ≥ 20 indicate moderate, severe, or very severe depression | Higher scores indicate more depression or mood disorder |
Headache frequency | Number of days in the last month with a headache | NA | The higher the frequency the worst the health status |
HIV symptom checklist | In Ironson et al.,71 experimenters assessed symptoms relevant to HIV (based on the Centre for Disease Control and Prevention criteria for Category B symptoms) by interview using a HIV symptom checklist Symptoms were assessed for the previous month at baseline and the 1-month visit, and for the previous 6 months, at the 6- and 12-month visits; thus, symptoms were assessed during the complete follow-up period | Examples of symptoms are herpes zoster (shingles), oral thrush, cervical dysplasia, pelvic inflammatory disease, low platelet count (50,000), peripheral neuropathy, chronic unexplained fever and chronic unexplained diarrhoea | More symptoms indicate a worse health |
HIV VL | HIV VL was determined using a quantitative reverse-transcriptase PCR assay (Amplicor HIV-1 Monitor, Roche Diagnostic Systems), which measures down to 400 copies of HIV RNA in plasma | Threshold not reported | A reduction in VL indicates better health |
HIV-OS | The HIV-Specific Optimism Scale (HIV-OS) is a self-report measure of optimistic beliefs related to HIV issues Seven items were adapted from the LOT (Scheier and Carver209) specifically for Wagner et al.73 Sample HIV-OS items include ‘I am not counting on things going my way in the course of my HIV infection’ and ‘Although the future course of my HIV infection is uncertain, I expect the best’ | 6-point Likert scale ranging from strongly disagree to strongly agree | Higher scores indicate higher levels of optimism related to HIV issues |
IBS-QoL | The Irritable Bowel Syndrome QoL | Scale 0–100, best = 100 | Higher scores indicate better QoL |
IBSSS | The irritable bowel severity (IBS) scale/scoring system (IBSSS; Francis et al.210) is a 9-item survey designed to enable clinicians to record and monitor the severity of IBS Participants have to answer the questions based on how they feel currently (i.e. over the last 10 days or so) A total IBS severity score is given |
| Higher scores indicate increase in IBS severity |
IES | The Impact of Event Scale (IES; Horowitz et al.211) assesses frequency of intrusive thoughts and avoidance over the past week including today. Participants are asked to specifically refer to their cancer experience when answering the questions | Responses for each item are 0 (not at all); 1 (rarely); 3 (sometimes); 5 (often) Possible score ranges from 0 to 40 | Higher scores indicate the greater extent to which participants have experienced each item, in the preceding 7 days |
IES-R | The Impact of Event Scale-Revised (IES-R; Weiss and Marmar212), which contains 22 items that measure avoidance, intrusive re-experiences and arousal associated with a traumatic event | 5-point scale ranging from 0 (not at all) to 4 (extremely) | Higher scores indicate greater extent to which participants have experienced each item in the preceding 7 days in relation to their psychotic experiences and treatment |
IS | The 8-item Insight Scale (IS; Birchwood et al.213), which measures three dimensions of insight: perceived need for treatment, awareness of illness and relabelling of symptoms as pathological | Response to each item reported as agree, disagree or unsure | NA |
K-10 | The Kessler Psychological Distress Scale (K-10) detects non-specific emotional distress and has been used in a number of population health surveys in Australia. It contains 10 statements covering the preceding 4 weeks | 5-point Likert scale from 1 (none of the time) to 5 (all the time) Possible scores range from 10 (no distress) to 50 (maximal distress) | Higher scores indicate higher distress |
LIFE | The Longitudinal Interval Follow-Up Evaluation (LIFE; Keller et al.214) is a semistructured interview for assessing the longitudinal course of psychiatric disorders It consists of a semistructured interview, an Instruction booklet, a coding sheet, and a set of training materials. An interviewer uses the LIFE to collect detailed psychosocial, psychopathological, and treatment information for a 6-month follow-up interval The weekly psychopathology measures (psychiatric status ratings) are ordinal symptom-based scales with categories defined to match the levels of symptoms used in the Research Diagnostic Criteria The ratings provide a separate, concurrent record of the course of each disorder initially diagnosed in patients or developing during the follow-up Any DSM-III or Research Diagnostic Criteria disorder can be rated with the LIFE, and any length or number of follow-up intervals can be accommodated. The psychosocial and treatment information is recorded so that these data can be linked temporally to the psychiatric status ratings | NA | NA |
LIWC | The Linguistic Inquiry and Word Count (LIWC) is a text analysis software program designed by Pennebaker et al.19 LIWC calculates the degree to which people use different categories of words across a wide array of texts, including e-mails, speeches, poems, or transcribed daily speech. With a click of a button, you can determine the degree any text uses positive or negative emotions, self-references, causal words, and 70 other language dimensions (www.liwc.net/) | NA | NA |
LOT | The Life Orientation Test (LOT) assesses generalised positive outcome experiences measures optimism on eight items to indicate the extent to which they agree with each statement | 5-point Likert scales ranging from 1 (strongly agree) to 5 (strongly disagree) The items are summed to create a score ranging from 8 to 40 | Higher numbers indicate more optimism |
Mac New HRQOL | The Mac New Health Related Quality Of Life (Mac New HRQOL) scale is a 27-item measure of physical, emotional and social QoL (Valenti et al.215) In addition to separate physical, emotional and social QoL subscales, an overall index of QoL is provided. It has been extensively used in cardiac populations, and based on data from over 1000 cardiac patients | 7-point Likert scale. A change of 0.5 units reflects a minimal clinically important difference (Dixon et al.216) | Higher scores indicate better health |
Marks | The Marks Asthma Quality of Life Questionnaire (Marks; Marks et al.217) is a self-administered questionnaire intended for use with adults Respondents are asked to describe how troubling particular items have been over the past 4 weeks. Covers both physical and emotional impact Should not be confused with the Asthma Quality of Life Questionnaire (AQLQ; Juniper et al.218) | Scaling of items from 1 to 5 | NA |
McGill Pain Q-SF | The McGill Pain Questionnaire-Short Form (McGill Pain Q-SF; Melzack219) assesses these two dimensions of pain, as currently experienced by the patient. It contains 11 items assessing several domains of pain experience: intensity, sensory and affective | Scale from 0 (none) to 3 (severe) scale Ratings were averaged | Higher scores indicate greater severity |
McGill QOL | In Averill et al.,100 psychological and existential QoL were measured with the McGill QOL questionnaire to assess the subjective QoL of patients with terminal illness. Psychological QoL reflects the extent to which patients have experienced symptoms of depression, anxiety, sadness and hopelessness. There were six measures of psychological well-being that were highly correlated with each other: positive affect, negative affect, depression, psychological QoL, existential QoL and spirituality Existential QoL reflects patients’ ratings of the worth and meaning of their life, their progress towards their goals, their control over their life and the value of each day | 11-point Likert scale ranging from 0 to 10 Scores are summed up into a total score | Lower scores indicate better health |
MDASI | The MD Anderson Symptom Inventory (MDASI; Cleeland et al.220) is used to assess multiple symptoms experienced by cancer patients and the interference with daily living caused by these symptoms. Participants rate the severity of 13 core symptoms (in the last 24 hours) common across all cancer diagnoses and treatments and the extent to which these symptoms interfere with daily activities In Park and Yi78 a Korean version (Yun et al.221) was adapted | From 0 (symptom has not been present) to 10 (the symptom was as bad as you can imagine it could be) | Higher scores indicate greater severity and interference |
MIDAS | The Migraine Disability Assessment Scale (MIDAS) is a 5-item inventory that assesses the number of days in the past month when the respondents functioning was reduced or impaired because of headaches (behavioural disability from headaches) including days of work (including housework), school or other activities missed, as well as the number of days for which productivity was reduced by half A total of five items are calculated and analysed | The number of days is added up, totalling a final number of days from questions 1–5 MIDAS scores thresholds are as follows:
| Higher scores indicate greater migraine disability |
Mississippi Scale for PTSD | The Mississippi Scale for combat-related PTSD (Hebrew version) is a 35-item self-reported questionnaire describing participant’s feeling on each of the items Items 2, 6, 11, 17, 19, 22, 24, 27, 30 and 34 are scored in reverse order The cut-off score for PTSD is set at 107, a score that correctly classifies 90% of all subjects as PTSD or non-PTSD Means for the three validation groups are as follows: PTSD 130 (SD = 18); psychiatric 86 (SD = 26); well adjusted 76 (SD = 18) | Each item receives a score of 1–5 Add all items to obtain the total score | A total score of > 107 indicates a diagnosis of PTSD |
MMSE-Korean | The Mini Mental State Examination (MMSE) is often taken to rate cognitive functioning difficulties in a relatively short time: in the present study, the Korean version of MMSE, named MMSE-K, was used in the included study by Hong and Choi67 The MMSE-K has 30 questions for rating and each question is counted as one point. The full score of MMSE-K is 30 points. It consists of seven subitems. The standard MMSE-K was slightly modified, combining time orientation and space orientation into orientation to which 10 points were allocated, and also unifying memory registration and memory recall to memory to which six points were allocated Diagnostic criteria of dementia in terms of the MMSE-K score are given as follows: a total score of > 23 points is classified as normal, 20–23 points as doubted as dementia and < 20 points as dementia | The score of each item is allocated as follows: (1) 5 points for time orientation, (2) 5 points for space orientation, (3) 3 points for memory registration, (4) 3 points for memory recall, (5) 5 points for attention and calculation, (6) 7 points for language, and (7) 2 points for comprehension and judgement | A total score of < 20 indicates dementia |
Modified MRC dyspnoea scale | The Modified Medical Research Council dyspnoea scale (MMRC) is an instrument to document subjective feeling of shortness of breath | From 0 (shortness of breath only with strenuous activity) to 4 (shortness of breath with minimal activity, even dressing or undressing) | Higher scores indicate higher subjective feeling of shortness of breath |
MOS-HIV | The Medical Outcomes Study HIV Health Survey, a brief, multidimensional and comprehensive measure of HRQoL used extensively in HIV/AIDS research (MOS-HIV; Wu et al.222) It measured the physical functioning, pain, and mental health using three subscales:
|
|
|
MPI | The Multidimensional Pain Inventory (MPI; Kerns223) is a 48-item self-reported questionnaire, divided in three sections In the first section, the participant responds about their pain, and how it affects their lives In the second section, the participant responds about how his/her spouse or significant others respond to them in that particular way when they are in pain In the third section, the participant responds to how often they do different daily tasks (such as washing dishes, going to the cinema, take a trip, or engage in sexual activities) Participants can also list any other pain-related problem | Section 1: 7-point Likert scale ranging from 0 (not at all) to 6 (extremely) Section 2: range from never to often Section 3: range from never to often The scoring procedure produces a mean score for each scale | Higher scores indicate greater pain |
MSPSS | The Multidimensional Scale of Perceived Social Support (MSPSS; Zimet et al.224) is a 12-item self-report measure used to measure perceived social support | 7-point Likert scale from 1 (very strongly disagree) to 7 (very strongly agree) | Higher scores indicate higher perceived social support |
NMCUES | The National Medical Care Utilisation Expenditure Survey (NMCUES; National Centre for Health Statistics225) It assesses multiple forms of health-care utilisation and behaviours over a period (3 months in Rosenberg et al.83) Questions addressed health-care utilisation patterns, current use of medicines and health-related behaviours (e.g. smoking, substance use) | NA | NA |
OQ-45.2 | The Outcome Questionnaire (OQ-45.2; Lambert et al.226) is a 45-item self-report measure intended for weekly assessment of client progress through the course of psychotherapy The OQ-45.2 produces a total score and three subscale scores (symptom distress, interpersonal relations and social role) | The total score is calculated by summing the patient’s ratings across all 45 items (range 0–180) | Higher scores indicate greater clinical improvement |
PAID | Problem Areas In Diabetes scale (PAID; Polonsky et al.227), otherwise not described | NA | NA |
Pain behaviour | In both included studies by Lumley et al.115 and Macklem,131 a structured observation system228 which was designed for RA patients, assessed overt pain behaviour At each evaluation, patients were videotaped in the examination room for 10 minutes by a camera in the doorway while they engaged in four standardised manoeuvres (walking, sitting, standing and reclining), which were presented in a random order. The research assistant operated the camera and refrained from interacting with the patient other than to give directions for the next behaviour Raters were trained to code these videotapes by the developer of the system (Francis J Keefe) and achieved high inter-rater reliability during training. Next, these raters, blind to experimental condition, reviewed study videotapes for the presence of seven pain behaviours: guarding, bracing, grimacing, sighing, rigidity, passive rubbing and active rubbing The 10-minute tapes were divided into 20 30-second epochs; the presence or absence of each pain behaviour during each epoch was recorded, and a total score of all behaviours across all epochs was calculated | NA | NA |
Pain intensity | In the included study by Cepeda et al.,85 patients rated their average pain intensity using a verbal numerical rating scale In the included study by Macklem,131 pain intensity was measured using a 100-mm VAS | Verbal numerical rating scale from 0 (no pain) to 10 (the worst pain imaginable) 100-mm VAS ranges from 0 (no pain) to 100 (pain as bad it can be) | Higher scores indicate more pain intensity |
PANAS-X(a) | The Positive and Negative Affect Schedule (PANAS; Watson et al.229) which contains 16 items (eight positive items and eight negative items) In Wagner et al.73 the same scale is reported as PANAS and defined as a 20-item scale with the same 5-point response options. Words that describe feelings and emotions, such as interested, distressed, and proud load on either the positive or negative affect factor (10 items each). In this study, participants were asked to rate their feelings during the past week, including today | 5-point scale ranging from 1 (very slightly or not at all) to 5 (extremely) | Higher scores indicate greater mood change |
PANAS-X(b) | The Positive and Negative Affect Schedule–Expanded Form (PANAS-X, Watson and Clark230) was applied to assess emotional states of patients: 60-item scale, which was created to assess not only general dimensions of emotional experience, but specific emotional states too It included the original PANAS assessing short-term mood fluctuations, with consistent psychometric results in varying populations and over various time frames: this measure consists of two 10-item scales for positive and negative affect In addition to the two original higher order scales, the PANAS-X measures 11 specific affects: joviality, self-assurance, attentiveness, fear, sadness, guilt, hostility, shyness, fatigue, serenity, surprise | 5-point scale ranging from 1 (very slightly or not at all) to 5 (extremely) | Higher scores indicate greater mood change |
PANAS-X(c) | The Positive and Negative Affect Schedule for Children [PANAS-X(c); Laurent et al.231] is a 30-item scale, through which items are rated for affect during the past few weeks and averaged separately for positive affect (PA) and negative affect (NA) measures | 6-point scale from 0 (very slightly or not at all) to 5 (extremely) | Higher scores indicate greater mood change |
PANAS-X(d) | The Positive and Negative Affect Schedule–Abbreviated version of the expanded version [PANAS-X(d), Watson and Clark232] was used in the included study by D’Souza et al.101 The four negative moods were highly correlated (e.g. alpha for session 1 was 0.75 for tension and 0.73 for migraine samples), so the four ratings were averaged into one negative mood score and analysed it separately from calmness | Items rated from 1 (not at all) to 7 (a great deal) for four negative moods (anger, guilt, sadness, fear) and for calmness | Higher scores indicate greater mood change |
PANAS-X NA subscale | The 10-item negative affect subscale from the 60-item PANAS-X rated the frequency that they experienced each item during the prior 2 weeks | 5-point Likert scale ranging from 1 (not at all) to 5 (extremely) | Higher scores indicate greater mood change |
PASI | The Psoriasis Area and Severity Index (PASI; Feldman et al.233) is an internationally accepted, clinician-rated, psoriasis-specific score, based on the body surface area involved and on semi-quantitative estimation of erythema, infiltration and scaling; it is by far the most common tool in clinical studies and in daily practice. The head, trunk, and upper and lower extremities are assessed | Scores range from 0 (no psoriasis) to 72 (extremely severe psoriasis) | Higher scores indicate greater psoriasis severity |
PDS | The Posttraumatic Stress Diagnostic Scale (PDS; Foa et al.234), a 49-item self-reported measure, aids in PTSD diagnosis and symptom severity, with items that parallel DSM-IV criteria A diagnosis of PTSD is made only when DSM-IV criteria A–F are met The PDS includes a symptom severity score. Respondents rate 17 items representing the cardinal symptoms of PTSD experienced in the past 30 days. Finally, respondents rate the level of impairment caused by their symptoms across nine areas of life functioning | 4-point scale Scores range from 0 to 51, and this is obtained by adding up the individuals responses of selected items The cut-off points for symptom severity rating are:
| Higher scores indicate higher PTSD symptoms |
PedsQL | The Paediatric Quality of Life (PedsQL) is a 23-item well-validated scale with excellent internal consistency – how much of a problem various physical activities, feelings, social situations, and school activities have been in the past month QoL domains were restricted to (a) physical (eight items) and (b) psychosocial (15 items) | 5-point scale from 0 (never a problem) to 4 (almost always a problem) | Lower scores indicate better health |
PSA spec – CD4+/8+ | Peripheral blood T-cell proliferation to specified antigens This technique was assessed by the cell census proliferation assay method. It involves the use of a fluorescent membrane dye that partitions between daughter cells at division, in conjunction with flow cytometry to measure the proliferation of cells With mathematical deconvolution of the fluorescence histograms, the precursor frequency of cells in the original population that responded to a specific stimulus can be derived By using a second tagged fluorescent antibody to stain for lymphocyte subsets, the proliferation of specific phenotypes (CD4+/CD8+) of responding cells can be examined | NA | NA |
PHQ | The Patient Health Questionnaire (PHQ; Spitzer et al.,235,236) is designed as a screening instrument for use with health-care seeking populations It provides information on perceived symptoms of (a) depression, (b) anxiety, (c) somatic complaints, and (d) psychological distress The two subscales that measure symptoms of depression (nine items) and anxiety (15 items) employ DSM-IV criteria to screen for the presence of these psychiatric illnesses | For each item:
| Depression severity:
|
Physician’s global rating of disease activity | In Lumley et al.,115 the evaluating physician-rated patient’s overall disease activity with a 100-mm VAS In Macklem,131 scoring was done on a 5-point Likert scale | From 0 to 100 VAS, with anchors of 0 (no activity) to 100 (most activity) Range from 0 (asymptomatic), 1 (mild), 2 (moderate), 3 (severe) to 4 (very severe) | Higher scores indicate higher activity |
PILL | The Pennebaker Inventory of Limbic Languidness (PILL), a self-report questionnaire that assess the frequency of each of the most 54 physical symptoms The PILL can be scored by summing up the total number of items on which individuals score C, D or E (every month or so or higher) With this strategy, the mean score is 17.9 (SD = 4.5) based on a sample of 939 college students. You can also simply sum up the 54 items resulting in a mean score of 112.7 (SD = 24.7) (http://homepage.psy.utexas.edu/HomePage/Faculty/Pennebaker/Questionnaires/PILL.pdf) | From 0 to 216:
| Higher scores indicate participants are more nervous, distressed and unhappy |
POMS | The Profile of Mood States (POMS) (McNair et al.237) consists of 34 items aimed at assessing global negative and positive affect Participants indicate how often they experienced a particular feeling (e.g. liveliness, forgetfulness, unhappiness) since their cancer diagnosis or their last survey (for subsequent waves) In the included study by Henry et al.,53 mood disturbance was calculated by summing the negative affect subscales (e.g. anger, depression, tension, fatigue, confusion) and then subtracting the positive affect subscale score (e.g. vigour) In the included study by Smyth et al.,9 the POMS assessed current mood states using subscales for depression–dejection, tension–anxiety, fatigue–inertia, vigour–activity, anger–hostility and confusion–bewilderment | Scale from 0 (not at all) to 4 (extremely often) | Higher scores indicate greater mood disturbance |
POMS-n | The negative affect subscale of the Profile of Mood States (POMS; Zevon and Auke238) was measured in Jensen-Johansen et al.76 with a 37-item version validated for use with patients with breast cancer (Di Lorenzo and Williamson239) | Scale from 0 (not at all) to 4 (extremely often) | Higher scores indicate greater negative affect |
POMS-SF | The Short Form of the Profile of Mood States (POMS-SF; Shacham240) is a 37-item questionnaire that comprises six subscales measuring transient states of six moods: tension–anxiety, depression–dejection, anger–hostility, vigour–activity, fatigue–inertia and confusion–bewilderment Total mood disturbance is assessed as the sum of the scores for these six moods | 5-point Likert scale, ranging from 0 (not at all) to 4 (extremely) | Higher scores representing greater mood disturbance, except for vigour/activity, where higher scores indicate lesser mood disturbance and the score of this subscale is subtracted from the sum of the rest to provide the total mood disturbance |
Poor sleep quality | The poor sleep quality scale used a 4-item scale designed to evaluate the previous night’s sleep regarding sleep quality, degree to which sleep was restorative, waking daytime level of alertness, and ability to concentrate | 1–7 scale and averaged | Higher values indicate poorer sleep |
Post mTBI Symptom Checklist | The Post Mild Traumatic Brain Injury (mTBI) Symptom Checklist comprised 30 items, describing symptoms that are commonly experienced in the following days or weeks after a mTBI The list comprises questions about physical changes, changes in thinking, changes in emotions or behaviours | NA | The higher number of items ticked, the greater post-mTBI symptoms |
PPMS | A Passive Positive Mood Scale (PPMS) was developed for the study by Jensen-Johansen et al.,76 using words reflecting non-active positive mood to supplement the active positive mood items of the POMS vigour subscale The PPMS consists of items reflecting passive positive mood in the past 7 days (positive/bright, balanced, glad, peaceful, relaxed, at ease, calm, contented) | NA | Higher scores indicate better passive positive mood |
PSC | The Paediatric Symptom Checklist (PSC) is a 35-item psychosocial screen designed to facilitate the recognition of cognitive, emotional and behavioural problems The PSC is the parent-completed version, as opposite to the Paediatric Symptom Checklist-Youth Report form (PSC-Y), which is the children-completed version (see p. 317) | Items are rated as never, sometimes or often present and scored 0, 1 and 2, respectively The total score is calculated by adding together the score for each of the 35 items | A positive score on the PSC indicates need of further evaluation by a qualified health or mental health professional Both false positive and false negative can occur and this should be interpreted by the appropriate professional |
PSC-Y | The Paediatric Symptom Checklist-Youth Report form (PSC-Y; Little et al.241) contains 35 items to obtain a child’s report of their emotional and behavioural problems The items describe specific emotions and behaviours, and the respondent is asked to indicate how often the items apply to them by checking always, sometimes or never |
| A positive score on the PSC-Y indicates need of further evaluation by a qualified health or mental health professional. Both false positive and false negative can occur and this should be interpreted by the appropriate professional |
PSQI | The Pittsburgh Sleep Quality Index (PSQI; Buysse et al.242) evaluated habitual sleep disturbances over a 1-month period It differentiates poor from good sleep quality by measuring seven areas (components): subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunction over the last month | Responses for each item are: 0 (very good); 1 (fairly good); 2 (fairly bad); 3 (very bad) The total score sums the seven item scores together | A total score of ≥ 5 is indicative of poor sleep quality |
PSS | The 14-item Perceived Stress Scale (PSS) measure was used to assess the degree to which participants found their daily lives over the period of the past 4 weeks to be unpredictable, uncontrollable and overloading The questionnaire is designed to quantify non-specific appraised stress over the previous month | From 1 (never) to 5 (very often) | Higher scores indicate higher levels of appraised stress |
PSS-I | The Post-Traumatic Stress Disorder Symptom Scale Interview (PSS-I; Foa et al.243) The PSS-I was used to generate three PTSD subscale scores for re-experiencing, avoidance, and arousal symptoms The PSS-I is a 17-item semistructured interview that assesses the presence and severity of DSM-IV PTSD symptoms related to a single identified traumatic event in individuals with a known trauma history. Each item is assessed with a brief, single question. There are no probes or follow-up questions. Interviewees are asked about symptoms they have experienced in the past 2 weeks | For each item, the interviewer assigns a rating to reflect a combination of frequency and severity from 0 (not at all) to 3 (five or more times per week/very much) | Higher scores indicate greater symptoms |
PTGI | The Post-Traumatic Growth Inventory (PTGI; Tedeschi and Calhoun244) measures the degree of positive changes reported after experiencing a traumatic event The PTGI measures growth in five domains: new possibilities, relating to others, appreciation of life, personal strength, and spiritual changes PTGI is a 21-item self-report inventory. In addition to an overall scale score, the PTGI comprises five factors:
| 6-point Likert type scale, ranging from 0 (I did not experience this change as a result of my crisis) to 5 (a very great degree as a result of my crisis) | Higher scores indicate greater positive changes |
QEDD | The diagnosis of eating disorder on the Questionnaire for Eating Disorder Diagnosis (QEDD; Mintz et al.245) is a 50-item diagnostic instrument based on DSM-I criteria | NA | NA |
QOL | The Quality of Life Scale (QOL; Burckhardt et al.246), used in Broderick et al.,118 is a 16-item instrument (rather than the 15-item one found in the Flanagan version) designed to measure QoL across a broad array of life domains in patients with chronic illness Independence, doing for yourself was added after a qualitative study indicated that the instrument had content validity in chronic illness groups but that it needed an item that reflected the importance to these people of remaining independent and able to care for themselves | 7-point Likert scale ranging from 1 (terrible) to 7 (delighted) The instrument is scored by summing the items to make a total score | Higher scores indicate better QoL |
RCMAS | The Revised Children’s Manifest Anxiety Scale (RCMAS; Reynolds and Richmond247) is subtitled What I Think and Feel, and contains 37 written statements describing feelings or behaviours that the individual is asked to respond to by circling yes or no This measure assesses the level and nature of children’s anxiety. The yes responses are counted to determine a total anxiety score. There a four subscales (for which scores can be calculated separately): physiological anxiety; worry/oversensitivity; social concerns/concentration; lie | NA |
|
RSQ | The Recovery Style Questionnaire (RSQ; Drayton et al.248) is a 39-item self-report measure with the categories developed by McGlashan et al.249 integration vs. sealing over styles of adaptation to psychotic illness The RSQ includes 13 aspects of recovery style, each of which is assessed by three items | Using a formula (Drayton 1998), the scores on each of these aspects are combined into the six following classifications along one dimension:
| Higher scores indicate greater recovery style |
Rumination Scale | The Rumination Scale (McIntosh et al.,250) consists of a 10-item report that assesses people’s tendency to engage in ruminative thinking | NA | NA |
SAM | The paper-and-pencil version of the Self-Assessment Manikin (SAM; Bradley and Lang251) obtains participant’s ratings of valence (pleasantness) and arousal in response to each session (self-reported emotion) | 9-point Likert-type scale:
| Higher scores indicate greater pleasantness |
SAPASI | The Self-Administered Psoriasis Area and Severity Index (SAPASI; Sampogna et al.252), a patient-rated, psoriasis-specific outcome measure, is a widely validated instrument that provides an objective measure of disease severity, and has been effectively used in previous studies Participants rate the colour, induration, and scaliness of an average psoriatic lesion using three modified VASs. As in the original PASI, the SAPASI weights the involvement of the head (H), upper extremities (U), trunk (T) and legs (L) as 10%, 20%, 30%, and 40% of the total body area, respectively | SAPASI = (0,1 × AH) + (0,2 × AU) + (0,3 × AT) + (0,4 × AL) | Higher scores indicate greater severity |
SCL-90-R | The Symptom Checklist-90-Revised (SCL-90-R) is a 90-item, self-report measure of current psychological symptomatology, including global psychological distress It is a multidimensional complaint list based on a self-assessment covering an important part of the compliant that can be seen in the psychiatric inpatient clinic | 5-point Likert scale ranging from 0 (not at all) to 4 (extremely) Items are summed for a total score | Higher scores indicate greater distress and psychological symptoms |
SCS | The Social Constraints Scale (SCS; Lepore and Ituarte253) is a 15-item scale assessing perceived inadequacy of social support resulting in reluctance among individuals to express thoughts and feelings about a specific stressor, in this case their cancer experience Example items include: How often did they avoid you? How often did they minimise your problems? How often did they tell you to try not to think about your cancer? and How often did they make you feel as though you had to keep feelings about your cancer to yourself, because they made him/her feel uncomfortable? In Zakowski et al.,84 two forms of the SCS were used: one asking about constraints from patient’s spouse or partner and one asking about constraints from people in their lives other than their spouse or partner (e.g. friends or family members) The mean of the two constraint scores in all analyses (among the 19 patients who had no current spouse or partner, the constraints from others score was used, in that we considered this score to be reflective of their average constraint level) were used in the aforementioned study | Scores range from 15 (low constraints) to 60 (high constraints) | Higher scores indicate higher social constraints |
SDSCA | Summary of Diabetes Self-Care Activities scale (revised) (SDSCA; Toobert et al.254) Splits into general diet, specific diet, exercise, blood glucose testing and foot care subscales | NA | NA |
Self-rated health status (a) | Compared with the person in excellent health, how would you rate your health at the present time? | 7-point scale from 1 (terrible) to 7 (excellent) | Higher scores indicate better health |
Self-rated health status (b) | How you rate your health overall? | From 1 (very bad) to 5 (very good) | Higher scores indicate better health |
Serum cytokine levels of TNF-α, IL-4 and IL-10 | Levels were determined using a high sensitivity ELISA sandwich essay In this method, the concentration of the selected cytokine in the serum is calculated from the linear portion of a standard curve of purified cytokine at known concentrations | The detection limits of the assay were < 0.25 pg/ml | The detectable range for TNF-α was 0.5–32 pg/ml and for IL-10 0.8–50 pg/ml |
Sexual health and performance | In the included study by Pauley et al.,82 sexual health and performance was assessed by a designed 6-item measure created by the authors The scale was intended to work as two separate subscales: one measuring performance and the other measuring sexual desire | NA | Higher scores indicate greater levels |
SF-12 | The Short Form questionnaire-12 items (SF-12; Ware et al.255) is a widely used, brief generic measure of self-reported health status derived from the larger SF-36 survey Self-ratings are made of severity and frequency of 12 physical and mental health problems, as well as of their impact on the patient’s overall perceived health status This modified version of the SF-36 has consistently been shown to have good reliability and validity | It yields both physical health and mental health summary scores, which are reported as standard scores | Slower scores indicated positive psychological and physical health |
SF-36 | The Medical Outcomes Short Form questionnaire-36 items (SF-36; Ware and Sherbourne256) is used to evaluate psychological (SF mental), physical health (SF physical) and general health The eight subscales include (a) limitations in physical activities because of health problems; (b) limitations in social activities because of physical or emotional problems; (c) limitations in usual role activities because of physical health problems; (d) bodily pain; (e) general mental health (psychological distress and well-being); (f) limitations in usual role activities because of emotional problems; (g) vitality (energy and fatigue); and (h) general health perceptions A physical health composite score embodies concepts (a), (c), (e) and (g) and a mental health composite score embodies concepts (b), (d), (e) and (f) This instrument has been also used a measure of HRQoL In the included study by Broderick et al.,118 four additional subscales from the MOS-SF-36 General Health Survey were selected: overall health, social functioning, health distress, and cognitive dysfunction. Three additional items assessing tiredness on awakening, tiredness during the day, and quality of sleep were rated over the past week on 4-point scales | 6-point Likert scale from 1 (excellent) to 5 (worst) | Lower scores indicated positive psychological and physical health |
SF-36v2 Health Survey | The SF-36v2 Health Survey (Ware257) is a 36-item inventory that yields eight scale scores and two summary scores for physical and mental health The 1998 US norm-based scoring in version 2 allows for ready interpretation of scores relative to general population norms The eight scaled scores are the weighted sums of the questions in their section. Each scale is directly transformed into a 0–100 scale. The eight sections are vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning and mental health In the included study by Broderick et al.,118 the Pain Catastrophising Scale served as a primary outcome, because it measures the physical health status of the patient. The Mental Component Summary (MCS) was also examined to determine whether a psychological impact of the intervention was observed | Total score in each component ranges from 0 to 100 | The higher the score the less disability |
SGRQ | The St George’s Respiratory Questionnaire (SGRQ) is a disease-specific instrument designed to measure impact on overall health, daily life and perceived well-being, to be used in patients with fixed and reversible airway obstruction It has 76 questions in three sections: symptoms (frequency and severity), activity (activities that cause or are limited by breathlessness) and impacts (social functioning and psychological disturbances resulting from airways disease) | Total score ranges from 0 to 100 | Higher scores indicate poor health |
SIP | The Sickness Impact Profile (SIP; de Bruin et al.258) used in the included study by Hughes54 is 136 items The SIP contains three items: the physical functioning scale, mobility subscale (SIP-m), and the recreation and pastimes subscale (SIP-r&p-t) The SIP describes activities of daily living divided in 12 categories | Numerical scale | Higher scores indicate greater dysfunction |
Skindex-29 | The Skindex-29 (Chren et al.259) has been shown to be a valuable tool for measuring HRQoL (QoL) in dermatological patients, as reported in the included study by Paradisi et al.110 Its Italian version was developed following guidelines for the cross-cultural adaptation of HRQoL measures and validated in a previous survey260 | VAS scale from 0 (no pain) to 10 (worst possible) | Higher scores indicate poorer QoL |
SOC | The Sense of Coherence Scale (SOC) is a 13-item self-report instrument (Antonovsky261) based on the following underlying constructs: comprehensibility, manageability and meaningfulness The SOC items are scored along the 7-point scale | 7-point scale with two anchoring phrases: ‘until now life has had no clear goals or purpose at all’ and ‘until now life has had very clear goals and purpose’ | Higher scores indicate a strong sense of coherence |
Social Constraints Scale | The Social Constraints Scale (Lepore et al.262) is a 15-item scale assessing perceived inadequacy of social support resulting in reluctance to express thoughts and feelings about a specific stressor, in this case, experience with amyotrophic lateral sclerosis (e.g. How often did they tell you not to think about amyotrophic lateral sclerosis?) All items referred to respondent’s experiences over the prior week | 5-point scale ranging from 1 (almost never) to 5 (almost always) | Higher scores indicate greater social constraint |
Somatisation Scale | The Somatisation Scale (13 items) includes 13 common physical complaints (e.g. stomach pain, back pain, headaches), from which a severity score can be calculated | Range 0–4 | NR |
SOPA | The control subscale of the Survey of Pain Attitudes (SOPA; Jensen et al.263) is a questionnaire to measure feelings of personal control over pain The SOPA is the most widely used measure of pain-related attitudes (De Good and Tait;264 Jensen et al.263) | 5-point scale from 0 (this is very untrue for me) to 4 (this is very true for me) After reversing responses on the four absence of control items, responses are summed to create a total score | Higher scores indicate greater control over pain |
SOS | The Significant Others Scale (SOS) measured how much practical and emotional support that individual provided responding to two questions for each item: Emotional support answered by:
| From 1 (never) to 7 (always) scale | Higher scores indicate greater emotional support |
SSQ Asthma | The Wasserfallen Symptom Score Questionnaire (SSQ): asthma subscale | NA | NA |
SSQ Awakenings | The Wasserfallen Symptom Score Questionnaire (SSQ): awakenings subscale | NA | NA |
STAI-S | The State/Trait Anxiety Scale (STAI-S) is a 20-item, self-report instrument that assesses the subjective feelings of apprehension, nervousness and anxiety at the moment | 4-point Likert scale ranging from not at all, somewhat, moderately so, to very much so | Higher scores indicate greater state anxiety |
Stigma Scale | The Stigma Scale, designed for individuals diagnosed with HIV/AIDS, consisted of 13 items that evaluated fear, avoidance, and perceived negative responses related to HIV status | 1–4 ordinal scale reported as strongly, not at all, rarely, sometimes, often Total scores ranging from a low of 13 to a high of 52 | Higher scores equating to greater stigma |
Survey–18 physical symptoms items | The Survey–18 physical symptoms items includes items derived from other reports for their appropriateness for the sample in the included study by Henry et al.53 (Anderson and Tewfik;265 Ganz and Coscarelli;266 Whelan et al.267) Example symptoms included fatigue, nausea, appetite loss, breast pain, hair loss, weight gain, hot flashes, itchiness or discomfort of the skin, decreased arm mobility and swelling of the arm | A 7-point scale was used, ranging from 1 (not at all) to 7 (severe) | Higher scores indicate greater physical symptoms |
SUS | The Social Undermining Scale (SUS; Vinokur and van Ryn268) assesses the extent to which each of the four most important people in participant’s lives caused them distress by acting in an unpleasant or angry manner towards them, criticising them or making their life difficult | 5-point scale | |
Swollen joint count | Joint swelling reflects local inflammation and limited motion in affected areas. The patient’s rheumatologist, blind to the patient’s experimental condition, evaluated 16 joints bilaterally (five interphalangeal and five metacarpal phalangeal joints in addition to shoulder, elbow, wrist, knee ankle and metatarsals, for a total of 32 joints) and the presence or absence of swelling was recorded for each joint | ||
Symptom and Emotion Self-report Survey | Participants rated the degree to which they were currently experiencing physical symptoms and emotions. The symptom items were averaged to yield a symptom score, and emotion items were averaged to form positive and negative emotion scores | 5-point scale from 1 (not at all) to 5 (a great deal) and scored | |
Symptom Checklist-90-Revised | Physical symptoms are reported on a 12-item somatisation subscale of the Symptom Checklist-90-Revised (SCL-90-R) In the included study by D’Souza et al.101 symptoms were rated regarding the past month, and ratings were totalled | Rated from 0 (not at all) to 4 (extremely) | |
SLESQ | The Stressful Life Events Screening Questionnaire (SLESQ) (10 items) includes 10 psychosocial complaints common among health-care seeking populations (e.g. difficulties with family support, problems with significant others, and financial concerns) | Range 1–4 | NR |
The Ways of Coping-Cancer Version | The Ways of Coping-Cancer Version is a self-report checklist of coping responses to cancer-related stressors It assesses the frequency of problem-focused and emotion-focused coping efforts | ||
TLEQ | The Trauma Life Experience Questionnaire (TLEQ; Kubany et al.269) is a 23-item self-report measure of 22 types of potentially traumatic events including natural disasters, exposure to warfare, robbery involving a weapon, physical abuse and being stalked TLEQ measures type and frequency of trauma event exposures, and responses to these exposures The TLEQ has strong psychometric properties (Kubany et al.269) and was completed at the baseline assessment Trauma exposure was scored only if the person indicated exposure to the traumatic event and a response to the event that was consistent with DSM-IV PTSD criterion A2 | For each event, respondents are asked to provide the number of times it occurred, ranging from never to more than five times, and whether fear, helplessness or horror was present: yes/no | Higher scores indicate greater trauma |
TLFB abstinence | Timeline Followback Method (TLFB) of assessing number of abstinent days | Larger number means longer abstinence | |
UCLA-Charles | The UCLA-Charles R Drew University Women and Family Project (Wyatt and Chin270) was adapted to assess changes in meaning and perceived benefits Participants were asked how, if at all, being HIV positive changed the way they think about themselves, changed them as a person, changed the way they are with other people, and changed their priorities Different categories were developed, based on the literature and on an initial analysis of 14 patients | Ten categories of positive changes, six categories of negative changes and three categories of mixed or neutral changes, as well as codes for uncategorised positive and negative changes The number of changes falling into the positive categories and negative categories was computed for each participant | Higher scores indicate greater changes? |
VSQ-9 | The Visit Specific Satisfaction Questionnaire (VSQ; Ware and Hays271), a self-report measure administered to participants and providers at the conclusion of the 3-month follow-up period | To score the VSQ-9, the responses from each individual should be transformed linearly to a 0–100 scale, with 100 corresponding to excellent and 0 corresponding to poor Responses to the nine VSQ items should then be averaged together to create a VSQ-9 score for each person | Higher scores indicate greater satisfaction related to the visits |
Walking speed and grip strength | In the included study by Lumley et al.,115 patients were instructed to walk as quickly as possible, but safely down a 50-foot corridor, and recorded the time to do so in seconds In addition, patient’s grip strength was assessed by having them squeeze, as firmly as possible, a sphygmomanometer bulb, and the pressure generated was recorded from two trials with each hand; all four values were averaged to a single score | NA | Walking speed: higher values mean slower walking Grip strength: higher values indicate better functioning |
Well-being | In the included study by Cepeda et al.85 each patient’s sense of general well-being was rated | 7-point Likert scale from awful to excellent | Higher scores indicate better well-being |
WHYMPI –pain subscale | The Pain Severity subscale of the West Haven-Yale Multidimensional Pain Inventory (WHYMPI; Kerns et al.272) is a 61-item self-report inventory across three domains The WHYMPI is for use in chronic pain populations. It generates 13 empirically derived scale scores, including pain severity, perception of how pain interferes with daily life activities, appraisals of the support received from significant others, and perception of how significant others respond to their displays of pain | From 0 to 6 | Higher scores indicate more extreme pain |
AIDS, acquired immunodeficiency syndrome; CD3+, Cluster of differentiation antigen 3-positive lymphocyte; ELISA, enzyme-linked immunosorbent assay; FIQ, Fibromyalgia Impact Questionnaire; HAQ, Health Assessment Questionnaire; IL-4, interleukin 4; IL-10, interleukin 10; NA, not available; NR, not reported; PCR, polymerase chain reaction; RAI, Rheumatology Attitudes Index; RNA, ribonucleic acid; VAS, visual analogue scale.
Quality assessment
TABLE 107
First author, year | Randomisation | Blinding | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Sequence generation? (Selection bias) | Method description given? | Allocation concealment? (Selection bias) | Outcome | Performance | ITT analysis? | Selective reporting? (Description of outcomes differences between groups) | Attrition bias? (Description of withdrawals) | Pre-specified criteria for eligibility of patients? | Similarity of groups at baseline regarding prognostic factors? | |
Abel 200450 | Y | N | U | U | U | Y | N | U | U | Y |
Arden-Close 201380 | Y | Y | Y | U | N | Y | N | N | Y | N |
Averill 2013100 | Y | Y | U | U | Y | N | Y | Y | Y | N |
Bartasiuniene 2011102 | Y | N | U | U | N | Y | N | N | U | Y |
Bernard 200693 | Y | Y | Y | U | U | N | N | N | Y | N |
Broderick 2004113 | Y | N | Y | U | N | Y | Y | Y | Y | Y |
Broderick 2005118 | Y | Y | Y | U | N | N | U | Y | Y | Y |
Canna 200694 | Y | N | Y | N | Y | N | N | U | Y | Y |
Cepeda 200885 | Y | N | Y | Y | U | Y | Y | Y | Y | Y |
Craft 201374 | Y | Y | U | U | U | N | N | Y | Y | Y |
Dennick 201488 | Y | Y | Y | Y | Y | Y | N | N | Y | Y |
D’Souza 2008101 | Y | Y | Y | N | Y | Y | N | N | N | Y |
Gellaitry 201075 | Y | Y | U | U | U | N | Y | N | Y | Y |
Gidron 199698 | Y | N | U | N | Y | Y | U | Y | U | N |
Gillis 2006119 | Y | Y | Y | U | Y | Y | Y | Y | Y | N |
Golkaramnay 200768 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
Graf 200895 | Y | Y | N | U | N | Y | N | N | Y | N |
Graham 200851 | Y | Y | Y | Y | U | N | Y | Y | Y | Y |
Grasing 201090 | N | N | N | U | U | U | Y | Y | Y | N |
Halpert 201052 | N | Y | N | U | N | N | N | Y | Y | N |
Hamilton-West 2007114 | Y | Y | Y | Y | N | Y | Y | Y | Y | U |
Harris 2005106 | Y | Y | Y | N | N | N | N | Y | N | N |
Henry 201053 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
Hevey 2012103 | Y | N | U | U | U | N | Y | N | U | U |
Hong 201167 | Y | Y | N | U | U | Y | U | U | Y | N |
Hughes 200754 | Y | U | N | N | N | Y | N | Y | Y | Y |
Ironson 201371 | Y | N | U | U | U | U | N | U | Y | N |
Jensen-Johansen 201376 | Y | Y | Y | U | Y | N | N | U | ||
Kraaij 201055 | Y | N | U | U | U | N | Y | Y | U | N |
Krpan 201396 | Y | U | U | U | U | U | N | U | U | U |
Lange 200369 | Y | N | U | U | Y | N | Y | Y | N | Y |
Lumley 2011115 | Y | N | U | U | U | Y | Y | Y | N | Y |
Lumley 2014116 | Y | N | N | U | U | Y | Y | Y | N | Y |
Mann 200172 | Y | N | U | U | U | N | N | Y | N | N |
McElligott 200687 | Y | U | N | N | U | Y | N | U | Y | Y |
Meshberg-Cohen 201091 | Y | U | U | U | U | Y | Y | N | Y | Y |
Milbury 201481 | Y | Y | U | U | U | N | N | Y | Y | Y |
Mosher 201277 | Y | Y | U | U | U | Y | U | Y | Y | Y |
Pauley 201182 | Y | Y | U | U | U | N | Y | N | Y | U |
Paradisi 2010110 | Y | Y | U | U | N | N | Y | Y | Y | Y |
Park 201278 | N | U | U | U | U | Y | U | U | Y | N |
Petrie 200456 | Y | Y | Y | U | U | U | N | U | Y | Y |
Richards 200097 | Y | N | U | U | U | N | U | Y | Y | Y |
Rickett 201166 | Y | N | U | U | U | N | N | Y | N | U |
Rini 201486 | Y | Y | Y | Y | Y | Y | U | U | Y | Y |
Robinson 200899 | Y | Y | N | U | Y | Y | N | N | Y | N |
Rosenberg 200283 | Y | N | Y | U | U | U | Y | U | Y | N |
Sharifabad 2010105 | Y | N | U | U | U | Y | N | U | Y | N |
Sloan 201270 | Y | Y | Y | U | U | U | N | Y | Y | Y |
Smyth 1999107 | Y | Y | Y | N | U | N | N | Y | Y | Y |
Smyth 2008121 | Y | N | U | U | U | U | Y | Y | N | U |
Stark 201057 | Y | Y | U | U | U | N | U | Y | Y | Y |
Tabolli 2012111 | Y | Y | Y | U | U | N | N | Y | Y | N |
Taylor 200389 | Y | N | U | U | U | Y | N | N | N | N |
Theadom 201058 | Y | N | U | U | U | N | N | Y | Y | |
Van Dam 201392 | Y | Y | Y | U | U | N | N | U | U | Y |
Vedhara 2007112 | Y | Y | U | U | U | Y | N | Y | N | Y |
Wagner 201073 | Y | Y | U | Y | Y | N | Y | Y | Y | U |
Walker 199979 | Y | N | U | Y | Y | N | N | Y | Y | N |
Wallander 2011109 | Y | Y | N | N | U | N | N | Y | N | Y |
Warner 2006108 | Y | Y | U | N | N | N | U | Y | Y | Y |
Wetherell 2005117 | Y | N | U | Y | U | N | Y | Y | Y | Y |
Willmott 2011104 | Y | Y | Y | U | Y | N | Y | N | Y | N |
Zakowski 200484 | Y | N | U | U | U | Y | Y | U | N | Y |
N, no; NA, not applicable; U, unclear meaning not reported; Y, yes.
TABLE 108
Number of studies | Quality assessment items |
---|---|
53 | Studies were truly randomised (a valid method of randomisation was reported) |
24 | Studies were reported as randomised but the method of randomisation was not given |
18 | Studies were reported as having concealed the allocation of the sequence randomisation |
6 | Studies preserved blinding for outcome assessment |
11 | Studies preserved blinding during performance |
25 | Studies analysed the outcomes using the ITT approach |
44 | Studies reported outcomes differences between groups |
44 | Studies provided a description of withdrawals |
44 | Studies reported the prespecified criteria for eligibility of patients |
33 | Studies reported assessing similar groups at baseline |
- Characteristics of included studies - Does therapeutic writing help people with ...Characteristics of included studies - Does therapeutic writing help people with long-term conditions? Systematic review, realist synthesis and economic considerations
Your browsing activity is empty.
Activity recording is turned off.
See more...